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Abstract 
This study describes: 
1. Substrate binding assays investigating the effects of methanolic extracts of 
unfermented and fermented Rooibos on the binding of natural substrates to ovine 
adrenal microsomal and mitochondrial P450 enzymes, demonstrating the interference 
of substrate binding in the presence of the Rooibos extracts. 
2. The effects of selected flavonoids (quercetin, rutin and aspalathin) on the binding of 
natural substrates to ovine adrenal microsomal and mitochondrial P450 enzymes, 
demonstrating interference of substrate binding in the presence of the flavonoid 
compounds.  
3. Substrate conversion assays in non-steroidogenic COS-1 cells to investigate the 
effects of methanolic extracts of unfermented and fermented Rooibos on the activity 
of key steroidogenic P450 enzymes (CYP17A1, CYP21A2, CYP11B1, and 
CYP11B2), demonstrating inhibition of the catalytic activity in the presence of 
Rooibos extracts. 
4. The effects of selected flavonoids on the substrate conversion of the aforementioned 
key steroidogenic enzymes expressed in COS-1 cells. 
5. An investigation of the effect of methanolic extracts of unfermented and fermented 
Rooibos on steroid hormone production in human adrenal H295R cells under basal 
and stimulated conditions, demonstrating the modulating effects of unfermented and 
fermented Rooibos extracts. Basal and stimulated steroid hormone production was 
decreased in the presence of unfermented and fermented Rooibos. 
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Opsomming 
Hierdie studie beskryf: 
1. Die gebruik van substraatbindings-essais om die effek van metanoliese ekstrakte, van 
gefermenteerde- en ongefermenteerde Rooibos, op die binding van die natuurlike 
substrate aan skaap adrenale mikrosomale en -mitochondriale P450 ensieme te bepaal. 
Daar is getoon dat die ekstrakte 'n beduidende inhiberende effek op ensiem-
substraatinteraksie gehad het. 
2. Die die inhiberende effek van geselekteerde flavonoïede (kwersetien, rutien and 
aspalatien) op die binding van die natuurlike substrate aan skaap adrenale 
mikrosomale en -mitochondriale P450 ensieme. 
3. Die gebruik van substraatomsettings-essais in nie-steroïedogeniese COS-1 selle, om 
die effek van gefermenteerde- en ongefermenteerde Rooibos ekstrakte op die 
aktiwiteit van die steroïedogeniese P450 ensieme (CYP17A1, CYP21A2, CYP11B1, 
and CYP11B2) se katalitiese aktiwiteit te bepaal. Daar kon aangetoon word dat die 
katalitise aktiwiteite van bg. ensieme beduidend beïnvloed word deur die Rooibos 
ekstrakte. 
4. Die gebruik van substraatomsettings-essais in nie-steroïedogeniese COS-1 selle, om 
die effek van geselekteerde flavonoïede op die aktiwiteit van bogenoemde 
steroïedogeniese P450 ensieme te bepaal. 
5. 'n Ondersoek na die invloed van  metanoliese ekstrakte van gefermenteerde- en 
ongefermenteerde Rooibos op steroïedhormoon biosintese in die menslike adrenale 
H295R-selmodel. Die ondersoek, onder basale en gestimuleerde toestande, het getoon 
dat beide Rooibosekstrakte in bogenoemde toestande steroïedhormoon produksie 
geinhibeer het. 
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16-OHPROG   16-hydroxyprogesterone 
17-OHPREG   17-hydroxypregnenolone 
17-OHPROG   17-hydroxyprogesterone 
17βHSD   17β-hydroxysteroid dehydrogenase 
A4    androstenedione 
ACAT   cholesterol acyltransferase 
ACE   angiotensin-converting enzyme 
ACTH   adrenocorticotropic hormone 
ADX/ Fdx   adrenodoxin 
ADXR/ FdR  adrenodoxin reductase 
AMP     adenosine monophosphate 
ANOVA  analysis of variance 
ALDO   aldosterone 
Ang II   angiotensin II 
AT1   angiotensin II receptor type 1 
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COS-1   transformed African green monkey kidney tumour cells 
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FC   free cholesterol 
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CHAPTER 1 
Introduction and objectives 
1.1. Introduction 
The traditional use of medicinal plants for therapeutic purposes in the maintenance of good 
health and in the treatment of diseases has been on-going for centuries. Southern Africa is an 
important focal point of botanical and cultural diversity but only a few species of plants have 
been commercialized as herbal or medicinal products (Van Wyk 2011). One of the Southern 
African plants that have gained local and global popularity is Aspalathus linearis generally 
known as Rooibos.  
Rooibos is unique to the Western Cape province of South Africa. It is commonly consumed 
as a beverage. It is processed in two different forms, fermented and unfermented Rooibos, 
both of which are commercially available. Rooibos is currently processed and sold in various 
forms, such as lotions, skin care products, ice tea and, most recently, as a red cappuccino. 
Although Rooibos is enjoyed  as  a  “tea”  competing  in  the  local  market  with coffee and 
Camellia Sinensis, it is popular as a herbal beverage in the international markets due to its 
health giving properties and high anti-oxidant content. Rooibos contains active compounds 
such as polyphenols to which the anti-oxidant activity is ascribed. Anti-oxidant activity and 
flavonoid content differ in the two forms of Rooibos with unfermented Rooibos having 
higher levels of flavonoids and greater anti-oxidant activity than fermented Rooibos. These 
differences are attributed to the fermentation process to which Rooibos is subjected after 
harvesting in order to acquire its unique sweet fruity flavour and colour (Joubert et al. 2011).  
Anecdotally, Rooibos has been reported to be used in treating ailments related to the 
endocrine system such as anxiety, stress, hypertension, and diabetes. Many of these ailments 
result from imbalances in the endocrine system abnormal adrenal hormone levels. The 
adrenal glands are situated on top of each kidney and are crucial for physiological 
homeostasis. Hormonal imbalances are associated with various clinical conditions which 
include, amongst others, cardiovascular diseases, diabetes, hypertension and metabolic 
syndrome. Steroid hormone biosynthesis is catalysed by cytochrome P450 enzymes which 
are heme monoxygenases expressed in the adrenal gland as well as the steroid 
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dehydrogenases which include 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid 
dehydrogenase (3βHSD and 17βHSD). These enzymes catalyse the biosynthesis of 
mineralocorticoids, glucocorticoids, and androgens (see Chapter 3). 
1.2.  Methodology 
First, the cytochrome P450 11β -hydroxylase (CYP11B1), aldosterone synthase (CYP11B2), 
cytochrome  P450  17α-hydroxylase/17,20 lyase (CYP17A1) and cytochrome P450 21-
hydroxylase (CYP21A2) and their role in steroid biosynthesis in the adrenal gland were 
discussed (Chapter 3). The unique spectral properties of these enzymes were used to 
investigate the effect of Rooibos and flavonoid compounds present in Rooibos on the binding 
of steroid substrates to the adrenal P450 enzymes (Chapter 4). Spectral binding assays were 
performed using ovine microsomal and mitochondrial preparations with progesterone 
(PROG) and deoxycorticosterone (DOC) as substrates. PROG is the substrate for both 
CYP17A1 and CYP21A2 present in the microsomal preparations while in the mitochondrial 
preparations, DOC is substrate for CYP11B1 and CYP11B2. The microsomal and 
mitochondrial P450 enzymes do not only differ with respect to their cell organelle location, 
but also have different electron transport systems (as is discussed in Chapter 3). 
The influence of Rooibos and the selected flavonoids on the catalytic activity of the P450 
enzymes which catalyse adrenal steroid hormone biosynthesis was investigated. Substrate 
conversion assays were carried out in COS-1 cells, a non-steroidogenic mammalian cell line, 
in which the P450 enzymes were heterologously expressed. The influence of Rooibos 
extracts were subsequently investigated in H295R cells, an adrenal cell model, to determine 
the effect on the overall steroidogenic output (Chapter 5).  
1.3.  Aims of the study 
The aims of the study are summarised below: 
x To investigate the influence of unfermented and fermented Rooibos extracts and 
selected flavonoids on substrate binding to P450 enzymes in microsomal and 
mitochondrial preparations. 
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x To investigate the influence of unfermented and fermented Rooibos extracts and 
selected flavonoids on the catalytic activity of P450 enzymes expressed in COS-1 
cells. 
x To investigate the influence of unfermented and fermented Rooibos extracts on 
steroidogenesis in a human adrenal cell model (H295R). 
1.4.  Layout of the document 
Chapter 1 comprises a brief introduction of the study, the aims of the study, and the 
methodology followed. 
A detailed overview of Rooibos and flavonoids is presented in Chapter 2. Chapter 2 also 
presents reported clinical effects of Rooibos on in vitro and in vivo investigations. 
An overview of P450 enzymes that catalyse steroid hormone biosynthesis and their role in 
steroid biosynthesis in the adrenal glands is presented in Chapter 3. 
Chapter 4 addresses the use of the unique spectral properties of P450 enzymes and the use 
thereof to investigate the effect of Rooibos and selected flavonoid compounds present in 
Rooibos on the binding of steroid substrates to the adrenal P450 enzymes. 
Chapter 5 describes an investigation into the influence of Rooibos and the selected flavonoids 
on the catalytic activity of the P450 enzymes that catalyse adrenal steroid hormone 
biosynthesis. The influence of Rooibos extracts on H295R cells, an adrenal cell model, was 
also investigated and described in Chapter 5, to determine the effect on the overall 
steroidogenic output. 
Chapter 6 comprises of the summary and conclusions of results obtained in the study. Future 
work investigations for the continuation of the study are suggested in Chapter 6. 
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CHAPTER 2 
Rooibos (Aspalathus linearis). 
2.1. Introduction 
Plants have been used for medicinal purposes for centuries; most traditional cultures depend 
on plants not only for food but for medicine. Herbal preparations have been typically 
prepared by heating the plant material in water to produce an extract that could be used as a 
herbal beverage (tisane) or ointment. Plants are considered to induce fewer side effects and 
less toxic than synthetic drugs. According to the World Health Organisation, 80 % of the 
world’s  population  use  plant  extracts,  often  in  aqueous  solutions, for their primary health 
care. Herbal preparations have been used for centuries as tisanes in Europe and Asia (Loew & 
Kaszkin 2002; Patel et al. 2012). Such plants include the Camella sinensis, Cyclopia (honey 
bush tea) and Rooibos (Figure 2.1). These plants have been used for medicinal purposes 
based on anecdotal evidence rather than scientific evidence.  
 
Figure 2.1. Rooibos plantation (reproduced from www.newlands.ca). 
Rooibos’s  botanical  name  is  Aspalathus linearis (A. linearis), family – Fabaceae (pea 
family), tribe Crotalarieae (woody shrubs). The plant species is endemic to the Cape Flora. 
Rooibos is a leguminous plant indigenous to South Africa, is now popular on the 
international market as a caffeine-free beverage with low alkaloid tannins and seemingly 
poises as an elixir of life. Rooibos production is one of the most successful and important 
indigenous industries in South Africa  (Van Wyk 2011). Rooibos is cultivated and produced 
Stellenbosch University  https://scholar.sun.ac.za
  
5 
 
in the Western Cape. Nowadays it is not only consumed in South Africa but also exported to 
the rest of the world because of its popularity and international demand (Joubert et al. 2008). 
The use of A. linearis as a tisane by the Khoisan was first reported by Carl Thunberg in 1772 
(Hawkins et al. 1983). The Khoisan crudely processed Rooibos plant material in warm 
summer months by bruising it and leaving it to ferment in heaps and then drying it in the sun. 
In 1904, Benjamin Ginsberg, a merchant of Clanwilliam and the first to exploit Rooibos 
commercially started trading with it in Cederberg. Carl Thunberg noted that the Khoisan 
people used Rooibos as a medicinal plant and referred to Rooibos as Rooibosch or Rooitee. 
Its medicinal value was only realised by P. Le Fras Nortier, a medical practitioner and nature 
lover from Clanwilliam in 1930 (Joubert & de Beer 2011). It was marketed in 1904, in its 
fermented form, that is, the  oxidised form and, only recently Rooibos is now on the market 
in its unfermented form which is the un-oxidised form of Rooibos (McKay & Blumberg 
2007; Joubert et al. 2008).  
Rooibos is an erect or prostrate plant, which grows up to 152.4 cm (Figure 2.1). The plant is 
easily recognisable by its woody red stem, needle-like leaves and small yellow pea-like 
flowers as shown in Figure 2.2 (van der Merwe et al. 2006; Erickson 2002). Rooibos is 
adapted to poor nutrient, sandy, and acidic soils as it has roots that extend more than 200 cm 
deep into the soil to reach soil water. It has root nodules that contain bacteria which coverts 
nitrogen into nitrates to nourish the plant and the plant, in turn, provides carbohydrates and 
shelter for the bacteria (Hawkins et al. 1983; Kanu et al. 2013). It regenerates by re-sprouting 
or re-seeding after fire and it plays an ecological role in nitrogen-fixing (van der Bank, 1999; 
Cocks & Stock, 2001). Cultivation of the plant is susceptible to attacks from fungal disease 
(Neocosmospora vasinfecta and Diaporthe phaseolorum) and insect attacks such as the 
clearwing moth. Control of the attacks by chemical spraying is not desirable as the demand 
for organically produced Rooibos is high; thus developments of integrated pest management 
which include biological control management is currently being developed (van der Merwe et 
al. 2006). The plant’s leaves and stems go through two manufacturing processes to produce 
unfermented and fermented Rooibos. The traditional and modern processing fermentation 
methods gives the fermented Rooibos its unique red brown color and sweet taste, while the 
unfermented  Rooibos  or  “green”  Rooibos  is  obtained  by  preserving  the  green  leaves  and 
stems, and ensuring oxidative changes are kept to a minimum (Joubert et al. 2008). 
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Figure 2.2. Rooibos plant (A.linearis) (reproduced from of www.anniesremedy.com) 
As shown in Figure 2.3, Rooibos seedlings are grown in a nursery from hand collected seeds 
from healthy mature Rooibos plants in late January. The seedlings are transplanted into fields 
by hand or planting machines from the nursery when they have reached a specific height (10-
20 cm). Rooibos is harvested during summer months and early autumn, preferably no flowers 
should be present as they give an uncharacteristic flavor to the Rooibos tisane. Harvesting is 
done manually using sickles or mechanically by cutting only the top half of the plant when it 
has grown 150 cm in height (Van Niekerk & Viljoen 2008). 
After harvesting the shredded branches are bound and left overnight until it is processed the 
following day to wither the leaves. Processing of the tea involves batch processing which 
enables product flavor differentiation for a specific market (Joubert & Müller 1997). 
Processing involves either bruising (during which water is added); fermenting and drying in 
the sun after harvesting to produce fermented Rooibos, or immediately drying the Rooibos in 
the sun after harvesting to produce unfermented Rooibos (Figure 2.3). Bruising whilst adding 
water is necessary to accelerate fermentation initiated during shredding, also the water 
extracts polyphenols that will give colour the stems when absorbed. Pre-drying some plant 
material in the sun after harvesting inactivates enzymes responsible for the fermentation step 
thus skipping the fermentation step. The skipping of the fermentation step retains the green 
colour and flavonoid content of the Rooibos, particularly asphalathin (Joubert et al. 2011). 
For fermentation to take place, the shredded and bruised Rooibos is placed into heaps in 38 - 
42 ° C ovens where the fermented Rooibos develops its unique red colour and sweet taste 
[www.klipopmekaar.co.za]. The plant material is spread out in the sun to dry after 
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fermentation, sieved to obtain the required fine cut, steam pasteurised and packaged. The 
unfermented Rooibos also undergoes steam pasteurisation before it is packed. Steam 
pasteurisation before packing was introduced after Salmonella contamination was reported 
(Joubert et al. 2011). 
 
Figure 2.3. Rooibos plantation A) planting and harvesting process B) processing and packaging 
stages. 
Rooibos contains secondary plant metabolites that exhibit biological activities contributing to 
its health giving properties. The beneficial properties of Rooibos are linked to the unique 
phenolic constituents in the plant, some of which are modified enzymatically during 
fermentation (Heerden et al. 2006). Flavonoids form the largest class of polyphenols and are 
natural metabolites that are ubiquitous in plants. Flavonoids are classified into groups 
according to their carbon skeleton properties. Flavonoids have the diphenylpropane carbon 
skeleton and have potent biological activities in the prevention of chronic illnesses (Rice-
Evans et al. 1996; Scalbert & Williamson 2000; Gross 2004). Due to the processing methods, 
the flavonoid composition of the unfermented Rooibos differs from that of the fermented 
Rooibos (Standley et al. 2001). Flavonoids occur in A. linearis and the predominant 
polyphenols are the dihydrochalcones, flavanols and flavones (Joubert & de Beer 2011). 
Flavonoids have been found to have anti-inflammatory, anti-oxidant, anti-mutagenic, anti-
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tumor, anti-fungal and anti-viral activities. The flavonoids have been reported to be 
responsible for the anti-oxidant activity of Rooibos (Arct & Pytkowska 2008). 
 Unfermented Rooibos has been reported to exhibit a higher anti-oxidant activity than the 
fermented Rooibos, attributed to the phenolic composition. Some flavonoids also have 
phytoestrogenic activity due to their structural similarities with steroid hormones (Mesiano et 
al. 1999). Green tea and black tea have been extensively studied for their health giving 
properties and, in particular the chemopreventive properties (van der Merwe et al. 2006). 
Some Rooibos studies that have been done, show that Rooibos has health promoting 
properties as it alleviates stress, anxiety, nervous tension and insomnia (Van Niekerk & 
Viljoen 2008). Most importantly, Rooibos has been reported to be safe for consumption by 
infants and pregnant women and, no side effects have linked to the consumption of Rooibos 
have been reported (McKay & Blumberg 2007). There are still more studies yet to be done to 
give more information on the Rooibos’s health properties.  
2.2. Flavonoids and their chemical structure and classes.  
Flavonoids are a diverse group of secondary metabolites which are common in plant based 
foods such as wine, soya, vegetables, fruits, cereals and, herbal infusions (Hanhineva et al. 
2010). They are plant chemicals (phytochemicals) responsible for plant pigmentation. 
Concentrations of flavonoids vary from plant to plant, plant’s environmental factors and how 
the plant will be processed to make different types of flavours and colours (Moline et al. 
2000). It is understood that flavonoids are not nutrients as they are not essential for life and 
usually occur in small amounts in plants. Physiologically, flavonoids act as anti-oxidants and 
screen for harmful radiation in plant tissues (Hashimoto & Tajima 1980; Rice-Evans et al. 
1996). They also protect the plant from insect diseases, infestations and oxidative injury 
(Harborne & William 2000). Humans and animals do not have the ability to synthesise 
flavonoids making it important to have flavonoids in their diets (Yao et al. 2004). They are 
important for biological activities as they influence physiological or cellular activities that 
result in a beneficial health effect in mammals, thus they are also referred to as bioactive 
compounds.  
Flavonoids contain at least one benzene ring and a pyran ring with one or more hydroxyl 
groups together with other substituents (Xiao & Kai 2012). The two aromatic rings are 
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connected together by a three carbon bridge (Figure 2.4A). Flavonoids are classified 
according to the numbering of the carbon skeleton as previously mentioned in the 
introduction. A basic flavonoid skeleton can have a number of substituents such as hydroxyl, 
isopentyl and methyl groups. Water solubility and lipophilic nature of flavonoids is 
determined by the hydroxyl groups and methyl groups respectively (Crozier et al. 2009). In 
addition to the numbering of the carbon skeleton, the substitutions and functional groups on 
different positions of the skeleton enable flavonoids to be put into distinctive groups as 
shown in section 2.3, Table 2.1.  Flavonoids  and  their  metabolites’  biological  activities 
depend on their chemical orientation and structure of their moieties (Yao et al. 2004). Some 
of the flavonoids exist as glycosides; molecules in which a sugar is attached to a non-
carbohydrate moiety (small organic molecule). Most plants store chemicals as inactive 
glycosides which are then activated by enzyme hydrolysis.  
 
Figure 2.4. Structure of some flavonoids A) Basic flavonoid chemical structure, B) Dihydrochalcone 
chemical structure, C) flavonol chemical structure and, flavone chemical structure (Crozier et al. 
2009). 
The major classes of flavonoids are flavanols (Figure 2.4C), flavones (Figure 2.4D), flavan-3-
ols, anthocyanidins, flavanones and isoflavonones while the dihydrochalcones (Figure 2.4B) 
are the minor class (Appleton 2010). The paramount flavonoids in Rooibos are 
dihydrochalcones, flavones and flavanols (Joubert & de Beer 2011).  
2.3. Flavonoid compounds in Rooibos 
Rooibos tisane is a polyphenol rich infusion and important source of flavonoids. Flavonoids 
are significant and widely studied compounds in relation to health. They are of low toxicity in 
mammals when taken in recommended amounts (Appleton 2010). Rooibos contains three 
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prime classes of flavonoids as mentioned earlier in the previous section (Table 2.1); 
dihydrochalcones, flavanols, and flavones (Persson et al. 2010).  
Table 2.1. Chemical structures of Rooibos flavonoids with ring labeling. A) dihydrochalcones, B) 
flavonols, C) flavones (Joubert, Beelders, et al. 2012). 
Structure Compound Sustitution 
A) Dihydrochalcones    
Nothofagin R1=H, R2=C-β-D-glucosyl 
Aspalathin R1=OH, R2=C-β-D-glucosyl 
B) Flavones 
 
  
Orientin R1=C-β-D-glucosyl, R2,R4= OH,R3=H 
Isoorientin R1=H, R2,R4= OH,R3= C-β-D-glucosyl 
Vitexin R1=C-β-D-glucosyl, R2= H,R3,R4=OH 
Isovitexin R1,R4=H, R2= OH,R3= C-β-D-glucosyl 
Luteolin R1,R3=H, R2=R4= OH  
Luteolin-7-O-
glucoside 
R1,R3=H, R2= O-β-D-glucosyl,R4= OH 
Chrysoeriol R1,R3=H, R2= OH, R4=OCH3 
C) Flavonols 
 
  
Quercetin R=OH 
Isoquercitrin R= O-β-D-glucosyl 
Hyperoside R= O-β-D-galactosyl 
Rutin R= O-β-D-rutinosyl 
Quercetin-3-O-
robinobioside 
R= O-β-D-robinobiosyl 
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Flavonoid content varies with the quality of the Rooibos as higher quality grade contains 
higher levels of flavonoids ( Joubert, et al. 2012).  HPLC-DAD method was used to quantify 
the levels of flavonoids in the different grades of Rooibos by Joubert et al. (2012). A similar 
study was performed Beelders et al. (2012) to quantify the flavonoid content in aqueous 
extracts of unfermented and fermented Rooibos from two producers, Table 2.2.  
Table 2.2. Phenolic mean content values in aqueous extracts of unfermented and fermented Rooibos 
plant material (Beelders et al. 2012). 
Content values expressed in g per 100g soluble solids ± standard deviation 
P1= producer 1, P2= producer 2 
nd= not detectable 
Major flavonoids were identified in fermented Rooibos were aspalathin, isoorientin, orientin 
and also for the first time quercetin-3-O-robinobioside, an isomer of rutin. Quantitative 
analysis also showed that flavonoid content in Rooibos differs between producers (Beelders 
Phenolic compound 
Unfermented 
Rooibos (P1) 
Unfermented 
Rooibos (P2) 
Fermented 
Rooibos(P1) 
Fermented 
Rooibos (P2) 
PPAG 0.25 ± 0.051 0.44 ± 0.056 0.53 ± 0.10 0.60 ± 0.15 
Isoorientin  0.72 ± 0.120 1.30 ± 0.160 1.30 ± 0.084 1.2 ± 0.16 
Orientin 0.48 ± 0.080 0.81± 0.080 0.92 ± 0.053 0.92 ± 0.13 
Aspalathin 8.40 ± 1.40 12.4 ± 1.000 0.64± 0.170 0.68 ± 0.190 
Ferulic acid nd nd 0.09 ± 0.040 nd 
Quercetin-3-O-rutinoside 0.43 ± 0.068 0.91± 0.120 0.94± 0.160 nd 
Vitexin 0.093 ± 0.015 0.18 ± 0.017 0.19± 0.016 0.18 ± 0.013 
Hyperoside  0.046 ± 0.0079 0.18 ± 0.046 0.26 ± 0.076 0.26 ± 0.073 
Rutin 0.30 ± 0.047 0.42 ± 0.018 0.23 ± 0.140 1.2 ± 0.300 
Isovitexin 0.13 ± 0.021 0.23 ± 0.029 0.20 ± 0.017 0.21± 0.014 
isoquercitrin 0.090± 0.015 0.24± 0.038 0.18± 0.110 nd 
Nothofagin 0.69 ± 0.120 1.7 ± 0.160 0.10 ± 0.026 0.071 ± 0.013 
Stellenbosch University  https://scholar.sun.ac.za
  
12 
 
et al. 2012). Heinrich et al. (2012) reported a 98 % decrease in aspalathin content during the 
fermentation of Rooibos which had been investigated and reported previously (Joubert & 
Villiers, 1997). Methanolic extracts as well as aqueous extracts unfermented and fermented 
Rooibos were analysed using the HPLC-DAD method during an investigation of Rooibos 
effects on glucocorticoid levels (Schloms et al. 2013). The data (personal communications), 
suggest that methanol and aqueous extracts had similar flavonoids levels. The aqueous 
extracts of unfermented Rooibos had higher concentrations of aspalathin and nothofagin than 
the aqueous extracts of fermented Rooibos, the same was observed in the methanolic extracts 
of unfermented and fermented Rooibos. Comparison of methanolic extracts and aqueous 
extracts of Rooibos showed that methanolic extracts contained higher levels of flavonoids 
than the aqueous extracts. Methanolic extracts of Rooibos were used to investigate further the 
effects of Rooibos on steroidogenesis in the current study. The extracts were quantified using 
the HPLC-DAD method that was used by Beelders et al. (2012) and Schloms et al. (2013), 
consequently the results will be discussed in Chapter 4 and Chapter 5. The effects of the 
methanolic extracts on steroidogenesis are discussed in Chapter 4 and Chapter 5 as well. The 
major flavonoids found in Rooibos are: 
Dihydrochalcones: Aspalathin and nothofagin are the dihydrochalcones found in Rooibos. 
Rooibos is the only source of aspalathin whereas nothofagin has other sources that include 
the plant Nothofagus fusca (Joubert 1996). Asphalathin has been reported to have higher anti-
oxidant and anti-mutagenic activities than other flavonoids. This adds to the novelty of 
Rooibos herbal infusion (de Beer et al. 2012). During fermentation, aspalathin is broken 
down to its flavone analogues; isoorientin and orientin as shown in Figure 2.5. Nothofagin, a 
3-deoxy analogue of aspalathin, is present in lower quantities in Rooibos than aspalathin. 
Nothofagin’s flavone analogues comprise of regioisomers, vitexin and isovitexin. It is known 
to be a good radical scavenger but cannot protect cell membranes from peroxidation (Snijman 
et al. 2009). The dihydrochalcones are unstable and their concentration decreases 
significantly during fermentation (Joubert, de Beer, et al. 2012) 
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Figure 2.5. Modified pathway of aspalathin oxidation during fermentation of Rooibos (Joubert et al. 
2011). 
Flavanols:  Flavonols are yellow in colour and are found in many plants. There are a number 
of flavonols found in Rooibos as shown in Table 2.2 but only rutin and quercetin are going to 
be discussed. Unlike other flavonols, rutin and quercetin are used as dietary supplements as 
they are found in many medicinal plants such as horse chestnuts, ginkgo and many others. 
Rutin, is abundant in many plants and is a flavonol glycoside used to decrease capillary 
fragility (Raymond 2009). Quercetin is the one of the most abundant and common flavonoid 
that has been extensively investigated. In human diets and plants, quercetin is present in 
glycosylated forms such as quercetin-3-O- rutinoside (rutin) and isoquercitrin (Vrba et al. 
2012). It has anti-oxidant activities and it increases absorption of vitamin C in mammals 
(Appleton 2010). Quercetin has been reported to have analgesic properties (Filho et al. 2008).  
 Flavones and isoflavones: These compounds are pale yellow, they exist as coloring agents 
in plants (Rice-Evans et al. 1996). They are structurally similar to flavonols but lack 
oxygenation at carbon 3. Rooibos contains low amounts of apigenin-8-C-glucosides (vitexin 
and isovitexin). Flavone and isoflavones are structurally similar to eostrogen thus are 
classified as phytoestrogens (Del Rio et al. 2013). Phytoestrogens are non-steroidal 
constituents of our diets and act as antagonists or agonists of estrogen receptors. They control 
the activities of the key enzymes in estrogen biosynthesis through binding to the receptor 
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(Brozic et al. 2006). These compounds play an important role in cancer prevention as they are 
associated with reduced cancer rates (Birt et al. 2001). 
Processing of Rooibos to produce fermented Rooibos, affects the flavonoid content 
adversely. The ratio of dihydrochalcones and flavonoids in Rooibos decreases with the 
fermenting process (Standley et al. 2001). As mentioned previously in this section, during 
fermentation, aspalathin is broken down or oxidised to flavones (isoorientin and orientin) 
thus the concentration of aspalathin reduces whilst that of flavones increases (see Figure 2.5), 
(Joubert & de Beer 2011). Not only is the flavonoid content affected by fermentation but also 
the colour and aroma of Rooibos. Heinrich et al. (2012) reported that the colour change of 
Rooibos during fermentation is based on non-enzymatic mechanisms of aspalathin 
degradation (Heinrich et al. 2012). Nothofagin has been reported to be structurally similar to 
aspalathin thus also undergoes oxidation during processing of Rooibos  (Bramati et al. 2002). 
2.4. Bioavailability of flavonoids 
The biological properties of Rooibos and its flavonoids in the mammalian body depend on 
their bioavailability. Bioavailability is the degree to which a drug or a substance becomes 
available to the target tissue. Evidence of a few phenolic compounds bioavailability has been 
obtained by quantifying or identifying their concentrations in blood plasma and urine. The 
bioavailability is determined after ingestion of known and quantified food content or 
ingestion of quantified pure flavonoids (Scalbert & Williamson 2000). Distribution and 
bioavailability in tissues and organs of each phenolic compound may be affected by its 
physical properties which include their differences in solubility, molecular size and polarity 
(Liu et al. 2004). However, bioavailability of polyphenols is affected by a number of factors 
(see Table 2.3) (D’Archivio et al. 2010).  
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Table 2.3. Factors that affect bioavailability of flavonoids (D’Archivio et al. 2010) 
External factors Environmental factor (that is, sun exposure, degree of 
ripeness); food availability 
Food related factors Food matrix; presence of positive or negative effectors of 
absorption ( that is, fat fibre) 
Food processing related factors Thermal treatments ; lyphylisation; methods of culinary 
preparation; cooking;  homogenisation; storage; cooking 
Interaction with other foods Bonds with proteins(that is, albumin) or with polyphenols 
with similar mechanism of absorption 
Polyphenols related factors Chemical structure; concentration in food; amount 
introduced 
Host related factors Intestinal factors (that is, enzyme activity; intestinal transit 
time; colonic microflora) 
Systematic factors (that is, disorders; pathologies; gender 
and age; genetics; physiological conditions 
2.5. Absorption and metabolism of flavonoids 
Little is known about absorption and metabolism of polyphenols and it is likely that different 
classes of flavonoids have different pharmacokinetics properties (Rice-Evans et al. 1996). 
The biological fate of the flavonoids in the human diets is complex and depends on a number 
of processes. It is believed that flavonoids cannot be absorbed after ingestion but are first 
hydrolysed to their aglycones by bacterial enzymes found in the intestines. There is evidence 
that flavonoids are absorbed along the gut but the mechanism has not been established yet. 
There are suggestions that the hydrolysed simpler molecules of flavonoids are absorbed 
through passive diffusion and sodium dependent glucose transporter 1 (Walle 2004). It is 
hypothesised that flavonoids are absorbed by passive diffusion after the conversion of 
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glycosylated flavonoids to aglycones by the colon microorganisms. After absorption, the 
flavonoids are metabolised to phenolic acids or conjugated compounds in the liver by 
sulfation or methylation (Yao et al. 2004). 
It has been apparent that hydrolysis of flavonoids starts in the oral cavity then aglycones are 
absorbed in stomach by passive diffusion and the glycosides are absorbed in the intestines. 
Only a small concentration of flavonoids is absorbed and most of the flavonoids ingested are 
metabolised to simpler components by the microflora in the colon and are subsequently 
absorbed (Raymond 2009). Bacterial hydrolysis of flavonoids occurs in the colon to a greater 
extent, and to a lesser extent in the oral cavity and small intestines (Saura-Calixto et al. 
2007). Recent reports were made by Del Rio et al. (2013) that some flavonoids diffuse 
through the small intestines into the blood but others, such as the flavonoid glycosides are 
cleaved to release their aglycone by lactase phloridzin hydrolase. The aglycone consequently 
diffuses through the walls of the intestine as a result of its increased lipophilicity and 
proximity to the cell membranes. Active sodium dependent glucose transporters 1 are 
involved in the transportation of the flavonoids through the small intestine. However these 
flavonoids and their aglycones are capable of inhibiting transporters in the small intestine 
(Del Rio et al. 2013). 
Metabolism of quercetin glycosides (rutin) starts in the small intestine primarily where the 
sugar moiety is removed by enzymatic reactions. The released quercetin may be converted to 
taxifolin by enteric bacteria or degraded to phenolic acids if not absorbed (Vrba et al. 2012). 
In vivo studies have shown that aspalathin is absorbed in the gut and undergoes bacterial 
action in the intestines forming free aglycones after oral administration. Seven and eleven 
days later, methylated aspalathin was found in the urine but not in plasma (Kreuz et al. 2008). 
Aspalathin and nothofagin bioavailability in human urine was confirmed by Breiter et al. 
(2011) as well as the methylated aspalathin which was the main excreted metabolite (Breiter 
et al. 2011).  
The form of the flavonoid seem to influence the rate of absorption as it has been suggested 
that quercetin (glucosylated form) is absorbed in significant amounts (Nijveldt et al. 2001). 
Moreover, absorption of flavonoids is influenced by other factors that include the molecular 
weight, size and the extent and type of esterification (Scalbert et al. 2002). Del Rio et al. 
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(2013) illustrated Metabolism of rutin to quercetin by colon enzymes where the sugar 
moieties are cleaved off to produce quercetin (Figure 2.6).  
 
Figure 2.6. Proposed quercetin-3-O-rutinoside bacteria catabolism pathway of in the colony of 
humans (Del Rio et al. 2013). 
Flavonoids have the ability to bind to serum proteins (Del Rio et al. 2013). Albumin is the 
prominent serum protein in blood responsible for binding of flavonoids. The degree to which 
flavonoid binds to albumin affects the rate of delivery to tissues and cells in the body as 
cellular flavonoid uptake is proportional to the unbound flavonoids (Xiao et al. 2012). 
Absorbed flavonoids are transported to the liver bound to albumin proteins to undergo phase 
II biotransformation or catabolised to simpler phenolic compounds before excretion in urine 
or bile (Cabrera et al. 2006; de Mejia et al. 2009). Phase II biotransformations usually occur 
in the colon and liver. In the liver, the flavonoids undergo sulfination or methylation and 
glucoronidation during biotransformation (Villaño et al. 2010). However the biotransformed 
flavonoids are converted to polar conjugates that can be easily excreted thus affecting the 
bioavailability of flavonoids (Raymond 2009). Methylated, sulphated and glucuronidated 
metabolites were found in human urine by Stalmach et al. (2009) during in vivo studies 
(Stalmach et al. 2009). 
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2.6. Beneficial health effects of Rooibos and its flavonoids 
Anecdotal reports suggest that the Khoisan were aware of the medicinal properties of 
Rooibos as they used it as a remedy to calm the nervous and digestive system, and to treat 
insomnia, allergies and skin diseases (Van Niekerk & Viljoen 2008). It has been widely 
reported that these characteristic health benefits of plant based foods and beverages are 
attributed by phytochemicals in plants, particularly Rooibos (Snijman et al. 2007). Some of 
the phytochemicals are available on the market some over the counter such as rutin and 
quercetin, just to name a few. Rutin is medically used in topical cream or is ingested for the 
maintenance of blood capillary integrity. Flavanols (rutin and quercetin) have been reported 
to have chemopreventative, cardioprotective, neuroprotective, anti-inflammatory and anti-
allergic activities (Appleton 2010). 
Rooibos has also been used as a milk substitute to treat colic in infants. Annekie Theron, a 
South African woman, discovered that the Rooibos infusion would ease her infant’s colic and 
since then, Rooibos has been recommended for the treatment of colic (Van Wyk 2011). Since 
Rooibos doesn’t contain caffeine and has low levels of tannins, it is safe for pregnant women 
to take as it will not cause them any discomfort and their blood iron levels will not be 
depleted (Council 2013). The consumption of Rooibos has been proven not to have any side 
effects. Marnewick et al. (2003) found that consumption of Rooibos tea by rats for a period of 
ten weeks did not result in adverse effects in either the liver or kidney. In a human study 
conducted by Marnewick et al. (2011), it was noted that upon consumption of six cups of 
Rooibos per day for six weeks, no side effects were reported. 
In vivo experiments on iron absorption were conducted on a group of volunteers administered 
elemental iron (16 mg) in the presence of Rooibos, black tea and water respectively. The 
amount of haemoglobin, ferritin and transferrin in blood plasma was measured after ingestion 
of iron and the results indicated that the mean iron absorption in the presence of Rooibos 
(7.25 %) or water (9.34 %) were similar but for the black tea (1.70 %) was much lower. The 
differences of iron absorption capacity between Rooibos and black tea were probably due to 
the lower levels in tannin in Rooibos (Heeseling et al. 1979). In the cosmetic industry, 
Rooibos has also been shown to reduce wrinkles to a greater extent than other teas 
(Chuarienthong et al. 2010). Rooibos was also shown to improve hair growth and condition. 
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Last but not least, it has been shown that Rooibos can be used as after sun lotion as it soothes 
the skin. The skin is the largest part of the body and is exposed to environmental oxidative 
stress, thus the introduction of Rooibos in topical cosmetic formulations become popular to 
reduce photo-aging and ultraviolet radiation damage (Mavon et al. 2004). These 
characteristics of Rooibos are believed to be related to its anti-microbial, anti-oxidant and 
anti-inflammatory properties (Tiedtke & Marks 2002). 
Recent  studies  have  shown  that  Rooibos’  biological  activities  include  antioxidant,  anti-
mutagenic, anti-cancer, anti-viral, anti-fungal, and anti-stress activity (Sarwar & Lockwood 
2010). Anti-oxidants are responsible for inhibiting oxidant formation or intercepting oxidants 
or repairing oxidant damaged cells or neutralising the oxidants by donating one of their 
electrons to the free radical. Oxidants are metabolites that cause oxidative stress which is a 
condition in which oxidant metabolites (free radicals) become toxic to the body. The 
condition could be due to overproduction of the free radicals or a change in protective 
cellular mechanisms (Kaur & Kapoor 2001; Erguder et al. 2007). Lifestyle, environment, and 
pathological conditions can result in excess oxidative stress which affects normal cellular 
processes leading to chronic diseases (Willcox et al. 2004). This condition damages the DNA, 
important proteins and cell membranes which eventually lead to cell death (Valko et al. 
2006). Studies have shown that both unfermented and fermented Rooibos exhibit anti-oxidant 
activities with unfermented Rooibos having a much higher activity than the fermented 
Rooibos (Joubert et al. 2008). The difference in the anti-oxidant activity is due to the 
oxidation of flavonoids during fermentation of Rooibos hence the change in flavonoid 
content (Joubert et al. 2011). 
Polyphenols have been shown to be more effective anti-oxidants in vitro than vitamin C and 
vitamin E because of their chemical structure which is ideal for free radical scavenging 
activity. Flavonoids have been documented to act as free-radical scavengers (anti-oxidants) 
because of their reducing properties as electron or hydrogen-donating agents (Rice-Evans et 
al. 1996). In vivo studies done by Marnewik et al. (2003) have shown that the flavonoids 
found in Rooibos mimic the activity of a α-tocophenol, a fat soluble anti-oxidant compound, 
thus act as anti-oxidants (Marnewick et al. 2003). Some flavonoids have been reported to 
exert their anti-oxidant activity by interacting with the cell signalling and modulate cell 
activities (Hatti et al. 2009). Their anti-oxidant activity is exerted by the flavonoids, either by 
Stellenbosch University  https://scholar.sun.ac.za
  
20 
 
scavenging the free radicals or inhibiting the activity of enzymes that generate free radicals 
(Nijveldt et al. 2001). Moreover, Oh et al. (2013) reported that anti-ooxidant activity of 
flavonoids usually occurs through redox mechanisms and allows the flavonoids to act as 
metal chelators, hydrogen donors, reducing agents and singlet oxygen quenchers. 
Most in vitro studies done by various investigators have shown that the unfermented Rooibos 
has a higher anti-oxidant capacity than the fermented Rooibos as previously mentioned. In a 
another study done by Joubert et al. (2004) where the scavenging capacity of flavonoids 
found in Rooibos was tested on oxidative radicals (DPPH and O2
-
), it was observed that the 
flavonoids asphalathin, quercetin, orientin and luteolin have anti-oxidant activities, though 
aspalathin and quercetin showed more anti-oxidant activity than the other flavonoids. Anti-
oxidant activity of Rooibos in cellular systems was observed in several investigations when 
roughly 20 µg/mL of the extract was used. The Rooibos concentration at cellular levels 
inhibited the generation of free radicals (McKay & Blumberg 2007).  
Soluble extracts of unfermented and fermented Rooibos extracts have inhibited lipid 
peroxidation in the presence of iron in liver microsomal preparation. In this investigation, 
formation of reactive substances that caused lipid peroxidation was measured (Marnewick et 
al. 2005). It has been reported that flavonoids are oxidised to quinones and dihydrochalcones 
after quenching radicals and that the new compounds exhibit higher anti-oxidant activity than 
the other flavonoids (flavones and flavonols) in Rooibos tea (Krafczyk et al. 2009).  
Anti-viral activity investigations of Rooibos have been done in the context of HIV. An 
investigation by Nakano et al. (1997) in infected MT-4 cells in the presence of acid 
polyssacharides extracted from Rooibos showed that the cytopathicity in HIV was 
suppressed. The suppression of the cytopathicity was shown by the inhibition of HIV virus 
binding to the MT-4 cells at a concentration of 25 μg/mL of Rooibos. This study showed the 
anti-viral activity of chemically extracted polyssacharides, but these polysaccharides have 
subsequently been reported not to be found in the Rooibos infusion made by steeping the 
leaves in hot water, (Erickson 2002). The unavailability of the polysaccharides in aqueous 
Rooibos regards the reported anti-viral activity of Rooibos not valid; thus more investigations 
need to be conducted in regard to its anti-viral activity. 
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In another study conducted in Japan, it was shown that concentrations ranging from 1 µg/mL 
to 100 µg/mL of Rooibos extract induced the production of antigen specific antibodies with 
an increase in interleukin-2 production in murine splenocytes (Kunishiro et al. 2001). 
Interleukin-2, which is normally produced during immune response to in the body by T-cells, 
is important for growth, proliferation and differentiation of T-cells (Waldmann 2006). There 
is still more studies to be done regarding the effects of Rooibos’ immunological properties. 
Anti-mutagenic properties of Rooibos against direct acting mutagens, (2 acetylaminofluorene 
and aflaxtoxin) that required metabolic activation, in the presence of aqueous Rooibos were 
investigated. A Salmonella typhimurium mutagenic assay was used and it was observed that 
mutagenesis was suppressed in the presence of Rooibos (Marnewick et al. 2000). It was 
suggested that the Rooibos inhibitory effects result from the interaction of the P450 enzyme 
responsible for the mutagen activation and the different constituents of the Rooibos extract. 
The Rooibos extract constituents are polyphenols which act as acceptors of electrons from 
NADPH from P450 enzyme mediated reactions; thus activation of the mutagens is 
suppressed. Moreover, it was suggested that the structure of flavonols allow the flavonols to 
act as nucleophilic centres enabling them to form flavonol-carcinogen adducts with 
electrophilic carcinogens thus preventing tumorigenesis (Marnewick et al. 2000). Marnewick 
colleborated with other scientists such as Sissing to investigate the effect of aqueous Rooibos 
on methylbenzylnitrosamine (a carcinogen) induced oesophageal cancer cells and they 
observed that there was a reduction in the mean total papilomma size. The reduction was 
noted due to the absence of large papilomas (>10 mm
3
) (Sissing et al. 2011). It has been 
reported that skin 12-O-tetra-decanoylphorbol-13-acetate (TPA) induced tumours on mice’s 
skin were reduced in the presence of topically applied fermented Rooibos extract, but in the 
presence of unfermented Rooibos extract, no tumours were observed (Marnewick et al. 
2005).  
A review of investigations of in vivo and in vitro effects of Rooibos in animal and humans 
was documented by Mckay et al. (2007) suggested that Rooibos has anti-mutagenic and anti-
cancer properties. One study done by Komatsu et al. (1994) observed that oncogenic 
transformation of mouse embryo cells induced by X-ray was suppressed as cell survival 
decreased in the presence of increasing concentrations of Rooibos. Lamosova et al. (2007) 
showed that proliferation and growth of muscle cells of the chick embryo was inhibited in a 
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dose-dependent manner of Rooibos extract. The inhibition was viewed from the decrease in 
DNA content in the presence of Rooibos.  
Luteolin and quercetin have been observed to induce apoptosis and reduce proliferation of 
thyroid and colon cancers respectively in vitro. It is not known whether these anti-cancer 
activities of these flavonols can occur in vivo due to their low concentrations in Rooibos 
(Mori et al. 2001). Orientin was shown to inhibit oxidative degradation of lipids, thus 
preventing cancer (Vrinda & Devi 2001). More studies are required to determine the 
mechanisms by which Rooibos exerts its anti-cancer properties.  
Diabetes is a condition in which an individual (usually mammals) has high blood glucose 
levels. The ceasing of insulin production or irresponsiveness of cells to insulin causes the 
high blood glucose levels. Untreated diabetes can lead to complications such as 
cardiovascular complications, retinal damage, miscarriages and renal failure (Fiorino et al. 
2012). It is also a lifestyle related chronic disease and treatment has been linked to regular 
intake of polyphenols which maintain redox homeostasis and cell signalling (Coetzee et al. 
2013). Aqueous Rooibos extract has been shown to have anti-diabetic properties as it lowered 
plasma triacylglycerols and cholesterol, plasma urea, creatinine and aminotransferase 
concentrations when compared with untreated diabetic rats (Ulicná et al. 2006). Aspalathin, a 
dihydrochalcone was reported to significantly reduce hyperglycemia in a dose-dependent 
manner. In addition to hyperglycemia reduction, aspalathin was reported to reduce glucose 
intolerance in mice by increasing glucose uptake and insulin secretion. The aspalathin was 
purified from unfermented Rooibos and concentrations ranging from 1- 100 µM were used to 
determine its effects on  insulin secretion from cultured pancreatic cells and cultured muscle 
cells in vitro, and fasting blood glucose of type 2 model mice in vivo (Kawano et al. 2009). 
Recent studies have shown that polyphenols have the ability to reduce the occurrence of 
diabetes by preventing pancreatic cell function disorder. Polyphenols have been reported to 
influence glucose metabolism through several mechanisms such as modulating hepatic 
glucose output, inhibiting carbohydrate digestion and glucose absorption in the intestine, 
stimulating secretion of insulin from the pancreatic cells, modulating glucose release from the 
liver and activation of insulin receptors which leads to glucose uptake in insulin-sensitive 
tissues (Hanhineva et al. 2010; Thomas & Pfeiffer 2012). Rutin has anti-diabetic properties as 
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it  decreases  blood  glucose  levels  in  streptozotocin  induced  diabetic  rats  by  inhibiting  α-
glucosidases enzymes that break down starch and disaccharides to glucose (Muller et al. 
2012). Sanderson et al. (2013), observed inhibition of lipid accumulation in mouse embryonic 
fibroblasts by 22 % and 15 % with 10 μg/mL  and  100 μg/mL  respectively  of  aqueous 
Rooibos soluble solids.  The group also noticed an increase in intracellular ATP 
concentrations in the cells which are associated with increased uptake of glucose. This study 
suggest the Rooibos soluble solids’ has potential in preventing obesity as it showed Rooibos 
solids to affect adipocyte metabolism and inhibit adipogenesis (Sanderson et al. 2013). 
Hypertension (high blood pressure), also known as the silent killer, is a condition that is 
usually underdiagnosed or inadequately treated. Most people with this condition are not 
conscious of this disease till they have their blood pressure taken. Hypertension is a major 
risk of chronic diseases such as cardiovascular and renal diseases (Steyn 2005). Clinical trials 
have demonstrated the benefits of controlling blood pressure. High blood pressure is usually 
treated by beta blockers or angiotensin converting enzyme (ACE) inhibitors amongst others 
but these treatments have adverse effects (Tedla et al. 2011). It is usually associated with 
mineralocorticoid excess (Blumenfeld & Sealey 1994), a steroid hormone that will be 
discussed in Chapter 3. 
Anecdotally Rooibos has been used as treatment of cardiac arrhythmias and hypertension. In 
a study done by Khan et al. (2006), it was shown that the aqueous extract of Rooibos had a 
smooth muscle relaxing effect that could have been mediated through activation of potassium 
channels and calcium antagonist mechanisms. Potassium channels play important roles in 
cardiac repolarisation, smooth muscle relaxation and insulin release, which are involved in 
regulation of physiological functions (Sandhiya & Dkhar 2009). Persson et al. (2006) has 
observed an increase in nitric oxide concentration in human endothelial cells when incubated 
with aqueous Rooibos extract. Nitric oxide inhibits ACE activity which is a key enzyme in 
the renin-angiotensin-aldosterone system (RAAS). RAAS is important for the regulation of 
blood pressure, electrolyte and fluid balance (Persson et al. 2006). The RAAS will be 
discussed in Chapter 3. In a cardiovascular in vivo study where 20 volunteers drank 400 mL 
of aqueous Rooibos, it was observed that Rooibos significantly inhibited ACE activity 
(Persson et al. 2010). The mechanism by which Rooibos inhibits the ACE activity was 
Stellenbosch University  https://scholar.sun.ac.za
  
24 
 
suggested to be a mixed type of inhibition involving non-competitive and competitive 
inhibition (Persson 2012). 
It has also been observed that flavonoids can inhibit and sometimes induce a large variety of 
enzyme activity in mammals (Hollman & Katan 1999). Flavonoids have been proven to be 
steroidogenesis modulators (Hatti et al. 2009). Some flavonoids have been reported to 
modulate steroid metabolism by altering the activity of P450 enzymes responsible for steroid 
glucuronidation, sulfonation and hydroxylation (Cheng & Li 2012). Schloms et al. (2012) 
observed that unfermented Rooibos methanol extract inhibited the activity of some 
cytochrome P450 enzymes, e.g, CYP 21-hydroxylase (CYP21A2) and CYP 17-
hydroxylase/17,20 lyase (CYP17A1). These enzymes are key enzymes in the biosynthesis of 
steroids particularly aldosterone (ALDO), a mineralocorticoid and its precusors, DOC and 
corticosterone (CORT) which are glucocorticoids (Schloms et al. 2012).  
The inhibitory effect of unfermented Rooibos methanol extract was observed in steroidogenic 
human adrenal carcinoma cells (H295R). It was observed that the total amounts of steroids 
decreased significantly in basal and forskolin stimulated cells in the presence of the 
unfermented Rooibos methanol extract. Moreover it was observed that ALDO and its 
precursors concentration was significantly reduced under forskolin conditions in the presence 
of Rooibos extracts (Schloms et al. 2012). Forskolin is a steroidogenesis stimulant as it 
mimics adrenocorticotrophic hormone (ACTH), to which the H295R cell line is not 
responsive. The HPA axis and RAAS will be discussed in Chapter 3. Dihydrochalcones 
flavonoids (aspalathin and nothofagin) have been shown to contribute to the alleviation of 
symptoms of adrenal steroidogenesis disorder. Their effects were shown in the reduction of 
total steroids produced by H295R cells under stimulated conditions in the presence of these 
flavonoids. Some enzymes’ activities of  the adrenal steroidogenesis system (CYP17A1 and 
CYP21A2) were inhibited by these flavonoids (Schloms et al. 2012). 
2.7. Interaction of flavonoids with P450 enzymes 
Cytochrome P450 enzymes are a functionally diverse group of heme proteins with broad 
substrate specificity. The enzymes are involved in the oxidation of exogenous and 
endogenous organic substances that include xenobiotics, steroids and lipids (Seden et al. 
2010). P450 enzymes also sustain homeostasis in mammals as they produce steroid hormones 
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that maintain homeostasis. It has been reported that these enzymes interact with flavonoids in 
three ways (Helene 2009); either by being inhibited or stimulated by flavonoids, or their 
biosynthesis is induced by the flavonoids or some P450 enzymes metabolise the flavonoids.  
Ohno et al. (2002) reported inhibition of H295R microsomal P450 enzymes by some 
flavonoids, particularly flavones and isoflavones. In this study, Ohno et al. (2002) described 
the inhibition to be a result of the hydroxyl group on the 6
th
 position of the pyran ring or the 
4
th
 position of the benzene ring of the flavonoids. Inhibition of these enzymes may aid in the 
decrease of basal concentrations of mineralocorticoids and glucocorticoids thus decreasing 
the risk of chronic diseases. In a recent study, it has been shown that non-hydroxylated 
flavones upregulate the expression of CYP11B1 causing the increase in cortisol production in 
H295R cells. This upregulation of this enzyme has profound adverse consequences that 
include high basal cortisol levels (Cheng & Li 2012).  
Since flavonoids are ubiquitous to plants, Platt et al. (2010) did a recent study on P450 
enzymes and several plants. Some cytochrome P450 enzymes expressed in genetically 
engineered Chinese Hamster cells were shown to be inhibited by Rooibos, green tea, some 
fruits and some vegetables. This inhibition aids in decreasing risks for cancer (Platt et al. 
2010). Continuous ingestion of herbal infusions, particularly Rooibos and guava, showed that 
it induced the biosynthesis of a very important intestinal P450 enzyme (CYP3A). CYP3A is 
involved in the metabolism of several important prescription drugs such as HIV protease 
inhibitors and calcium channel blockers (Matsuda et al. 2007). Hence, inhibition or low 
concentration of this enzyme may lead to blood and tissue toxicity. Vrba et al. (2012) 
recently reported flavonoid (quercetin) induction of P450 enzyme (CYP1A1) expression in in 
vivo experiments.  According  to  Vrba’s  report,  there  was an increase in the expression of 
CYP1A1 which metabolises drugs and is involved in the activation of pro-carcinogens (Vrba 
et al. 2012). 
2.8. Conclusion 
Rooibos has risen to worldwide popularity as it is a polyphenol rich herbal infusion 
containing low concentrations of tannin, known to be caffeine free. Not only is Rooibos 
popular, it has created a market in South Africa thus boosting the economics of the country 
by creating jobs. The herbal infusion contains high concentrations of anti-oxidants and is safe 
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to drink with no reported side effects or toxic effects as discussed in the previous sections. 
Rooibos herbal infusion is suggested to be a good option for those who like to drink mild, 
non-stimulating, or sedating beverages. Rooibos is processed to make two different kinds of 
Rooibos, the fermented and the unfermented Rooibos which are different in the way they are 
processed, taste and flavonoid content. The unfermented Rooibos is unique to other herbal 
infusions such as the black and green tea as it has a unique brick red colour accompanied 
with a sweet fruity taste. Unfermented Rooibos has higher levels of polyphenols than 
fermented Rooibos and thus is considered healthier than the fermented Rooibos.  
In vivo and in vitro studies done on Rooibos have corroborated some of the anecdotal reports 
about this herbal drink. Rooibos herbal drink’s  health  properties  include  alleviation  of 
symptoms of the digestive system, respiratory system, endocrine system, skin diseases, 
sleeplessness, and stress. Some investigations show that Rooibos affects some of the human 
body homeostasis mechanisms. Homeostasis mechanisms include the HPA axis, the RAAS 
and their elements such as the enzymes, in particular some of the P450 enzymes. The HPA 
axis and the RAAS will be discussed in the following chapter.  
In the chapter 4 and 5, there are investigations and discussions on the effects of Rooibos on 
steroidogenesis and P450 enzymes. These Chapters will provide more information in which 
type of Rooibos is more effective on affecting some of the key enzymes in the 
mineralocorticoid and glucocorticoid pathways of steroidogenesis. Also the investigations 
will provide scientific evidence for its proposed capacity to alleviate hypertension. 
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CHAPTER 3 
Adrenal steroidogenesis and cytochrome P450 enzymes 
3.1. Introduction 
Homeostasis  is  the  body’s  ability  to  maintain  and  regulate  its  inner  physiological 
environment in response to various stimuli. Stimuli, which influence homeostatsis can be 
physical, mental, or environmental. Internal or external stimuli, also referred to as stressors, 
can cause adverse effects on the regulation of physiological activities. The two main 
physiological systems in mammals that regulate and control homeostasis are the central 
nervous system and the endocrine system. Several organs in the human body, including the 
hypothalamus, pituitary, pancreas, thyroid, kidney, adrenal glands and gonads are involved in 
the maintenance of homeostasis. The brain maintains homeostasis through its control of the 
central nervous system, while the endocrine glands control homeostasis through the secretion 
of specific hormones. The adrenals and gonads specifically synthesise and secrete steroid 
hormones. Steroid hormones are communicative substances responsible for the maintenance 
of the reproductive processes, mineral balance and stress tolerance. 
Control and maintenance of steroid biosynthesis, also known as steroidogenesis, is important 
as it maintains and regulates a wide range of physiological functions. Changes in steroid 
levels in the body activate compensatory mechanisms to restore normal physiological 
functions as well as normal steroid concentrations. Steroid hormone imbalances lead to 
clinical conditions which include type 2 diabetes, cardiovascular diseases, metabolic 
syndrome, insulin resistance, renal failure, and hypertension. The regulatory mechanisms for 
steroid hormone biosynthesis include the hypothalamic-adrenal-axis (HPA-axis) and renin-
angiotensin-aldosterone-system (RAAS). The HPA-axis is activated by the secretion of 
corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) from the 
hypothalamus, which activates secretion of adrenocorticotropic hormone (ATCH) from the 
pituitary gland into the bloodstream. ACTH induces steroidogenesis, particularly 
glucocorticoid synthesis and secretion (Pariante & Lightman 2008), by binding to a receptor 
located in the adrenal. The RAAS is activated by the secretion of renin from the kidneys, 
which activates angiotensin II (Ang II) from angiotensinogen, which is secreted from the 
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liver. Ang II finally induces mineralocorticoid synthesis and secretion from the adrenals 
(Atlas 2007). These two systems are further discussed in section 3.7 of this Chapter.  
In the adrenal gland, more specifically in the adrenal cortex steroid production is catalysed by 
the steroidogenic enzymes, which include cytochrome P450-dependent and hydroxysteroid 
isomerase-dehydrogenase enzymes. Cholesterol, the initial substrate for adrenal 
steroidogenesis, undergoes a series of hydroxylation and lyase reactions to produce 
glucocorticoids, mineralocorticoids and adrenal androgens (Shimozawa et al. 1993). The 
plasma levels of these steroids are regulated by a negative feedback inhibition system on the 
HPA-axis and RAAS (Payne & Hales 2004). A dysfunctional HPA-axis and RAAS can lead 
to depression, stress, anxiety, cardiac diseases, kidney diseases, and diabetes. The 
concentration of corticosteroids such as cortisol (a glucocorticoid) and ALDO (a 
mineralocorticoid), can be measured in the blood and can serve as biomarkers for adrenal 
diseases (Stewart et al. 1993). 
3.2. Adrenal gland anatomy and zones of steroidogenesis 
Adrenal glands are endocrine encapsulated bilateral glands situated on top of each kidney. 
The glands are comprised of two functionally different tissue types that produce different 
types of hormones. The inner medulla (neurological tissue) is responsible for catecholamine 
production such as adrenaline (epinephrine) and norepinephrine while the outer cortex 
(glandular tissue), which forms the largest part of the adrenal, is responsible for steroid 
hormone biosynthesis (Engeland et al. 1997).  
The adrenal cortex is divided into three zones, the zona glomerulosa, zona fasciculata and the 
zona reticularis (see Figure 3.1). The selective expression of unique steroidogenic enzymes in 
each zone determines the unique steroids produced. The zona glomerulosa is the outermost 
zone which expresses enzymes responsible for the biosynthesis of mineralocorticoids. The 
zona fasciculata is the middle zone that expresses enzymes responsible for the biosynthesis of 
glucocorticoids. The zona reticularis expresses enzymes that catalyse the biosynthesis of 
androgens (sex hormones) (Rainey 1999; Rainey et al. 2002). 
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Figure 3.1. Functionally distinct zones of the adrenal cortex. The zona glomerulosa secretes 
mineralocorticoids, the zona fasciculata secretes cortisol and the zona reticularis secretes adrenal 
androgens (Wang & Rainey 2012). 
Each steroidogenic adrenal zone has its own distinct steroidogenic pathway, see Figure 3.2. 
The initial substrate for steroidogenesis, cholesterol, is converted to pregnenolone (PREG) in 
all the adrenal zones. The zona glomerulosa is distinguished from the other zones as it does 
not express CYP17A1 thus there is no production of cortisol or androgens (see Figure 3.2A). 
CYP17A1 is expressed in both zona fasciculata and zona reticularis, producing cortisol and 
androgens. CYP11B2 is expressed in the zona glomerulosa, which is important for the final 
steps in ALDO biosynthesis. Moreover, the zona glomerulosa expresses Ang II receptors 
(Slominski et al. 1999). Ang II is a hormone that stimulates ALDO biosynthesis and is under 
regulation of the RAAS which is discussed in section 3.7. 
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Figure 3.2. Steroidogenic pathways of the human adrenal cortex zones. Cholesterol is the initial 
substrate in all the zones. A) Biosynthesis of mineralocorticoids, mainly aldosterone, in the zona 
glomerulosa. B) Biosynthesis of cortisol and corticosterone in the zona fasciculata. Corticosterone is a 
minor glucocorticoid, synthesised in the absence of CYP17A1. C) Biosynthesis of androgen 
intermediates (dehydoepiandrosterone and dehydoepiandrosterone-sulfate) and androgen 
(testosterone) in the zona reticularis (Miller & Auchus 2011). 
CYP11B1 is expressed in the steroidogenic pathway in the zona fasciculata (Figure 3.2B) and 
this enzyme is responsible for the final steps in cortisol production. CYP11B1 can not 
synthesise ALDO from its precursor 18-hydroxycorticosterone (18OH-CORT) because of on 
the zone-specific CYP11B1 and CYP11B2 isozyme expression. The CYP11B2 transcript is 
localised in the zona glomerulosa whilst CYP11B1 is expressed in the zona fasciculata/ 
reticularis (Rodriguez et al. 1997; Bassett et al. 2002). Cortisol production is ACTH regulated 
as the zona fasciculata expresses receptors for ACTH. The zona reticularis (Figure 3.2C) 
produces small amounts of cortisol as it expresses CYP21A2 and 11β-hydroxylase to a lesser 
extent than CYP17A1 which ensures the synthesis of dehydroepiandrosterone (DHEA) and 
dehydroepiandrosterone- sulfate (DHEAS) (androgen intermediates) (Auchus & Rainey 
2004). 
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3.3. Adrenal steroid metabolism  
The enzymes that facilitate synthesis of steroids are expressed in the gonads and adrenal 
glands. Two groups of steroidogenic enzymes catalyse steroid metabolism in the adrenal 
glands; these are cytochrome P450-dependent enzymes, (discussed in section 3.5), and 
hydroxysteroid dehydrogenases (HSDs). HSDs do not contain heme and require cofactors 
(NADH, NAD
+
) to either reduce or oxidise steroids during steroid biosynthesis (Agarwal & 
Auchus 2005). Two HSDs, 3β-hydroxysteroid dehydrogenase (3βHSD)  and  17β- 
hydroxysteroid dehydrogenase (17βHSD),  take  part  in  adrenal  steroid  biosynthesis  (see 
Figure 3.3) (Payne & Hales 2004). 
 
Figure 3.3. Schematic representation of enzymes and steroids in the steroidogenic pathway. PREG, 
pregnenolone (PROG), progesterone (DOC), deoxycorticosterone (CORT), corticosterone. 18 
hydroxycorticosterone (18OH-CORT), aldosterone (ALDO), 17-hydroxypregnenolone (17-
OHPREG), 17-hydroxyprogesterone (17-OHPROG), dehydroepiandrosterone sulphate (DHEAS), 
dehydroepiandrosterone (DHEA). 
The first step in adrenal steroidogenesis involves the cleavage of cholesterol by CYP11A1 
enzyme located in the mitochondria, Figure 3.3. The rate limiting step of steroidogenesis is 
the uptake of cholesterol across the mitochondria membrane into the inner mitochondria 
membrane (Black et al. 1994). There three known sources of cholesterol which are, the 
denovo synthesis of acetyl CoA (acetyl coenzyme A), circulating low density lipoproteins 
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and hydrolysis of cholesteryl esters. Principally, cholesterol is obtained from circulating low 
density lipoproteins (Liu et al. 2000; Azhar & Reaven 2002). Cholesterol is hydrophobic and 
its uptake into the cells is mediated by the low density lipoproteins receptor which 
internalises the LDL via receptor mediated endocytosis. Once internalised, the low density 
lipoproteins is hydrolysed to free cholesterol by enzymes in lysozyme vesicles. The free 
cholesterol is transported to the mitochondria through the steroidogenic acute regulatory 
protein (StAR) transporter protein for steroid biosynthesis. Excess cholesterol is esterified  
and stored as acetyl CoA (Jeon & Blacklow 2006; Goldstein & Brown 2009). In rodents, the 
selective pathway (Figure 3.4) is used for high density lipoprotein instead of the endocytic 
pathway that is used in humans for low density lipoprotein (Azhar et al. 2003). ACTH, one of 
the tropic hormones, promotes acetyl CoA uptake in adrenal cells by stimulating a series of 
reactions as shown in Figure 3.4. The resulting steroids subsequently diffuse into the blood 
stream to be transported to their respective target tissues to elicit their effects (Mason & 
Rainey 1987; Brown et al. 1979; Gallegos et al. 2001). 
 
Figure 3.4. Cholesterol uptake and its metabolism for the biosynthesis of steroids in adrenal cortex 
cells. Free cholesterol (FC), acetyl CoA (CE), cyclic adenosine monophosphate (cAMP), high density 
lipoprotein (HDL), ACTH (H), low density lipoproteins (LDL), protein kinase (PKA), peripheral type 
benzodiazepine (PBR), cholesterol acyltransferase (ACAT), cholesterol ester hydroxylase (CEH), 
(Zaidi et al. 2012). 
The initial substrate for steroidogenesis, cholesterol, is converted to PREG in the 
mitochondria as mentioned earlier in section 3.2 (see Figure 3.3). PREG diffuses into the 
endoplasmic  reticulum (ER)  to be substrate  for  either 3βHSD or CYP17A1. CYP17A1 has 
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two activities, a lyase and a hydroxylase activity. CYP17A1 subsequently converts PREG to 
17D-hydroxypregnenolone (17OH-PREG) (hydroxylase) which is then converted to DHEA 
through the lyase activity. PREG, 17OH-PREG and DHEA then serve as substrates for 
3βHSD, which converts  these  substrates  to PROG, 17-hydroxyprogesterone (17OH-PROG) 
and androstenedione (A4) respectively, through the isomerase and dehydrogenase catalytic 
actions of 3βHSD. PROG then serves as substrate for CYP17A1 and CYP21A2. CYP17A1 
catalyses the hydroxylation of PROG to 17OH-PROG and A4 while CYP21A2 converts 
PROG and 17OH-PROG to DOC and deoxycortisol respectively (Payne & Hales 2004). 
DOC and deoxycortisol diffuse into the mitochondria to be further metabolised to CORT, by 
CYP11B1 and CYP11B2, and to cortisol, by CYP11B1. CYP11B2 subsequently converts 
CORT to 18OH-CORT and then to ALDO, the principal mineralocorticoid (Mason & Rainey 
1987; Swart et al. 1993; Albertin et al. 2002; Xing et al. 2011) 
3.4. The properties of Cytochrome P450-dependent enzymes  
Cytochromes P450 are heme containing membrane-bound proteins, associated with 
mitochondrial and endoplasmic reticulum (ER) membranes. They are found in all eukaryotes. 
The name of this group of enzymes is derived from the absorbtion peak observed at 450 nm 
when the reduced form of the enzyme is exposed to carbon monoxide (CO) in vitro (Omura 
& Sato 1964; Payne & Hales 2004).  
The heme is penta-coordinated, with the tretradentate poryphyrin ring contributing the four 
ligands, see Figure 3.5.  In the enzyme’s substrate free state (ferric state), a cysteine residue 
from the polypeptide contributes the fifth ligand, which is a thiolate sulphur atom, while the 
sixth position is thought to be occupied by water. Upon reduction the sixth position becomes 
the site for dioxygen binding. For the steroidogenic cytochromes P450, the enzymes are 
named according to the oxygenation position on the steroid ring, for example CYP11 (11-
hydroxylation), CYP17A1 (17-hydroxylation) and CYP21A2 (C21-hydroxylation) (Omura & 
Sato 1964).  
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Figure 3.5. Active site of P450cam (CYP101) with no substrate bound. The light blue color 
represents nitrogen, while the red color represents oxygen. The iron is dark blue color and the sulphur 
is yellow. The carbon skeleton is in coloured grey (www.tcm.phy.cam.ac.uk). 
The general catalytic cycle of P450 enzymes has been established and described in 9 steps 
(see Figure 3.6). The substrate binds to the iron in the active site inducing structural changes 
and a stable complex can be formed in the absence of reducing substances in vitro. During 
substrate binding, the iron will be in its ferric state (low spin). Upon substrate binding the 
distally coordinated water dissociates (step 1). The degree of substrate binding to the P450 
active site can be determined using difference spectroscopy to record the changes in the spin 
state of the heme iron (De Montellano 1995). The heme iron changes from high spin state 
(Fe
II
) to low spin state (Fe
III
) due to the conformational changes to yield a type I spectrum 
(A), with an absorption maximum at 390 nm and an absorption minimum at 420 nm. Certain 
inhibitors of steroidogenic cytochromes P450 can bind to the active site of the enzyme and 
induce conformational changes to produce type II difference spectra with an absorption 
maximum at 430 nm and an absorption minimum at 390 nm. 
 The conformational changes caused by the substrate binding to the active site also result in 
the reduction of the redox potential of the heme iron. Conformational changes lead to the 
reduction of the ferric, Fe
III
, to the ferrous, Fe
II
, by a single electron derived from NADH via 
a specialised electron transfer chain (step 2). The reduction of Fe
III 
to Fe
II 
allows oxygen 
(dioxygen) to bind to the enzyme to form a ferric superoxide complex (step 3). Between steps 
3 and 4 (step 3a), CO can interrupt the catalytic cycle by binding to the reduced P450 iron, 
yielding a type II or CO-induced difference spectrum. This spectrum has a peak maximum at 
450 nm and can be used to determine the P450 concentration in suspensions or solutions 
(Omura & Sato 1964). Type I and type II spectra are discussed further in Chapter 4. 
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 The introduction of a second electron (step 4) leads to the reduction of the ferric superoxide 
complex. Ferric superoxide complex is highly reactive and is protonated (step 5) to form a 
P450-peroxide complex. Addition of a second proton leads to the splitting of the dioxygen 
bond (step 6) with the release of one oxygen atom as a water molecule. The remaining 
oxygen atom forms an activated intermediate bound in the active site, which is inserted into 
the substrate as a hydroxyl molecule to form a hydroxylated product which is released from 
the active site (steps 7, 8 and 9). After hydroxylation, the enzyme returns to its original ferric 
form and the cycle is repeated (White & Coon 1980; Schliting et al. 2000). The intermediate 
formed at step 7 is believed to be the oxidative compound that was observed through a shunt 
pathway that uses hydrogen peroxide and benzoic acid as oxygen donors ( Denisov et al. 
2005). This pathway confirmed that the intermediate collects a hydrogen atom from the 
substrate to form a iron-hydrogen complex that recombines with the substrate to produce a 
hydroxylated compound that will form the product (White & Coon 1980; Denisov et al. 
2005). Upon specific substrate or ligand binding to the cytochrome P450-dependent enzyme 
active site, P450 protein conformational changes associated with low spin and high spin 
states have been detected spectrophotometrically (Pcam et al. 1987; Wilker et al. 1999; Lewis 
2005).  
Cytochrome P450-dependent enzyme catalytic activity changes are influenced by a number 
of factors which include competition for electrons from electron donors in the presence of 
another P450 enzyme, ionic interactions and conformational changes of cytochrome P450- 
dependent enzyme structure (Ener et al. 2010; Sushko et al. 2012). 
3.5. Electron transfer proteins of P450 enzymes 
Cytochrome P450-depedent enzymes are also called external monooxygenases because they 
use two electrons transferred by an external donor (NADPH) for catalysis. Electron transfer 
from a protein donor to P450 is important to control the activity of the enzyme (Hintz & 
Peterson 1981; Brewer & Peterson 1988). As shown earlier in section 3.3, cytochrome P450-
dependent enzymes catalyse hydroxylation reactions that involve substrate (RH) oxidation 
(addition of one oxygen atom) and reduction of the other oxygen atom to water (see Eq 1) 
(Munro & Lindsay 1996; Bernhardt 2006).  
RH + O2 + NAD(P)H + H
+
 → ROH + H2O + NAD(P)
+
   (Eq 1) 
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Figure 3.6. Catalytic cycle of cytochrome P450 enzyme. Reproduced and adapted  from (Krest et al. 
2013). 
Adrenal cytochrome P450-dependent enzymes are also classified into groups according to 
their electron transfer chains. The microsomal steroidogennic cytochrome P450 enzymes, 
CYP17A1 and CYP21A2, are membrane-bound enzymes in the ER while the mitochondrial 
cytochromes P450, involved in steroidogenesis, are CYP11A1, CYP11B1 and CYP11B2 
(Smith et al. 1994; Miller 2005). A schematic adrenal steroidogenesis diagram (see Figure 
3.7), illustrates the adrenal steroidogenic pathway in mitochondria and the ER. 
Stellenbosch University  https://scholar.sun.ac.za
  
37 
 
 
Figure 3.7. Steroid biosynthetic pathways in the adrenal cortex mitochondria and ER (Lewis 2005). 
3.5.1. Microsomal cytochrome P450-dependent enzymes 
Microsomal cytochrome P450-dependent enzymes are termed class II enzymes. These 
cytochrome P450-dependent enzymes receive their electrons from NADPH via cytochrome 
P450-oxidoreductase (POR). POR consists of a single polypeptide chain (Mr 78 000) and the 
active enzyme binds one mole of flavin mononucleotide (FMN) and one mole of flavin 
adenine dinucleotide (FAD) (Lu et al. 1969). During catalysis (see Figure 3.8), the FAD 
accepts a pair of electrons from NADPH to be reduced. The reduced FADH then transfers the 
electrons to FMN which subsequently releases the electrons, one by one, to the cytochrome 
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P450 during the catalytic cycle as previously described in section 3.5. This ensures that the 
reductase is a self-sufficient electron transfer unit, unlike the electron transfer system in type 
1 enzymes that depend on another protein (Oparian & Coon 1982). As shown in Figure 3.8, 
cytochrome b5, an electron transfer heme-protein, has been reported to have a differential 
stimulatory effect on cytochrome P450-dependent enzyme. Cytochrome b5 can donate the 
second electron, but not the first one, to microsomal cytochromes P450 during enzyme 
catalysis (Auchus et al. 1998). The availability of electrons is a rate limiting factor in 
microsomal cytochrome P450-dependent enzyme reactions. The electron transfer protein is 
also a key component in drug metabolism by microsomal cytochrome P450-dependent 
enzymes in the liver (Hintz & Peterson 1981; Brewer & Peterson 1988). Chapters 4 and 5 
report on investigations that were carried out on microsomal P450 enzymes, CYP17A1 and 
CYP21A2. 
 
Figure 3.8. Microsomal protein electron transfer system. POR, cytochrome P450-oxidoreductase and 
b5, cytochrome b5. (Miller & Auchus 2011). 
3.5.1.1. Cytochrome  P450  17α-hydroxylase/17,20 lyase and cytochrome P450 21-
hydroxylase 
CYP17A1 and CYP21A2 are microsomal enzymes expressed in the gonads and adrenal 
glands and are responsible for the biosynthesis of androgens and mineralocorticoid and 
glucocorticoid precursors.  
CYP17A1 is not expressed in the zona glomerulosa where ALDO, a mineralocorticoid, is 
synthesised, thus it can be assumed that this enzyme can determine adrenal zone specific 
steroidogenesis (Sparkes et al. 1991). It catalyses two reactions, the hydroxylation of PROG 
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to 17OH-PROG and PREG to 17OH-PREG as well as C17,20-lyase, or cleavage of the 
intermediate 17OH-PREG to DHEA. 
The hydroxylation reaction utilises two electrons to reduce one atom of oxygen to water and 
oxidise the substrate (Bernhardt 2006). The CYP17A1 hydroxylase activity is the first 
activity, and promotes glucocorticoid formation, while the C17,20-lyase activity is the second 
activity that promotes androgen formation (Baston & Leroux 2007). Both the 17 α-
hydroxylation and C17,20-lyase reactions occur at the same active site of CYP17A1 (Auchus 
et al. 1999). CYP17A1 and CYP21A2 are co-expressed in the zona fasciculata and their 
interactions are a mechanism for corticosteroid biosynthesis regulation, as they have the 
ability to inhibit each other, depending on their activities (Sushko et al. 2012). Cytochrome b5 
is a ubiquitous electron transport heme-protein that regulates the activity of CYP17A1. 
Cytochrome b5 stimulates the C17,20 lyase activity, but not the hydroxylase activity, of 
CYP17A1 in the zona reticularis. It has been reported that in the absence of cytochrome b5, 
CYP17A1 hydroxylase activity dominates, thus catalysing the production of negligible levels 
of sex steroids (Miller et al. 1997; Auchus et al. 1998).   
The mechanism of action of CYP17A1 is not yet fully understood, thus CYP17A1 has 
become a target for investigations. CYP17A1 is one of the P450 enzymes that undergoes 
phosphorylation and post-translational modification, which influences its rate of activity. 
CYP17A1 undergoes phosphorylation, and this mechanism has been hypothesised to be 
associated with some clinical conditions such as hyperandrogenism and insulin resistance 
(Zhang et al. 1995; Pandey et al. 2003). Defects of both CYP17A1 hydroxylation and 
C17,20-lyase reactions, due to mutations, lead to decreased levels of sex and glucocorticoid 
steroids, and mineralocorticoid excess. The decrease in sex steroids and glucocorticoids leads 
to sexual development disorders and hypertension (Hwang et al. 2011).  
CYP21A2 catalyses the hydroxylation of PROG and 17OH-PROG to DOC and 
deoxycortisol, which is the key step in glucocorticoid and mineralocorticoid formation. It is 
only encoded for by one gene and uses the same electron transport protein system that 
CYP17A1 uses (Scott et al. 2007). Unlike CYP17A1, CYP21A2 is expressed in all adrenal 
zones but only influences the production of corticosteroids (Payne & Hales 2004). CYP21A2 
deficiency leads to low blood pressure due to decreased cortisol and ALDO levels. Low 
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blood pressure has devastating clinical effects leading to conditions that include fatal 
cardiovascular diseases (Clayton 2002). 
3.5.2. Mitochondrial P450 enzymes 
Mitochondrial P450 enzymes are considered to be type I enzymes and they include 
CYP11A1, CYP11B1, and CYP11B2. These enzymes catalyse hydroxylation reactions in 
steroid biosynthesis. Unlike the type II P450 enzymes, type I enzymes depend on two 
electron transfer proteins, adrenodoxin (ADX) and adrenodoxin reductase (ADXR) denoted 
as Fdx and FdR respectively, see Figure 3.9. ADX and ADXR form a linked biomolecular 
complex. ADXR is an insoluble iron-sulphur protein, embedded in the inner membrane of the 
mitochondria together with the P450 enzyme. ADXR is a flavin moiety which accepts 
electrons (reduction of the ADXR) from NADPH and delivers them to ADX, which then 
dissociates from ADXR to deliver the electrons to the P450 enzyme. ADX thus functions as 
an electron shuttle between the ADXR and the P450 enzyme (Kimura & Suzuki 1967; 
Ziegler et al. 1999). 
 
Figure 3.9. Mitochondria protein electron transfer system. Adrenodoxin (Fdx), adrenodoxin reductase 
(FdR), (Bernhardt 2006). 
3.5.2.1. Cytochrome 11β-hydroxylase and aldosterone synthase 
CYP11B1 and CYP11B2 enzymes, also referred to as P450c11 enzymes, are located in the 
mitochondrial membrane of all three adrenal zones. The mitochondrial enzymes metabolise 
the final steps of glucocorticoid and mineralocorticoid biosynthesis (Fardella & Miller 1996). 
CYP11B1 catalyses the hydroxylation of deoxycortisol to cortisol while CYP11B2 catalyses 
a three step reaction that produces CORT, 18OH-CORT and ALDO (Imai et al. 1998). 
CYP11B1 is the most abundant P450c11 enzyme, expressed predominantly in the zona 
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fasciculata and to a lesser extent in the zona reticularis (Nishimoto et al. 2010). CYP11B2 is 
able to convert DOC to ALDO because it is only expressed in the zona glomerulosa where it 
has 11β-hydroxylase, 18-hydroxylase and 18-methyloxidase activities (Ogishima et al. 1991; 
Curnow et al. 1991). It has been noted that CYP11B1 and CYP11B2 can convert DOC to 
CORT and 18OH-CORT, respectively, but CYP11B1 cannot convert 18OH-CORT to ALDO 
(Mulatero et al. 1998). Studies on P450c11 have shown that both enzymes prefer to bind to 
DOC than intermediates (CORT and 18OH-CORT) and 18OH-CORT are not released from 
their active sites during steroid synthesis (Imai et al. 1998). Mutations of P450c11 can lead to 
congenital adrenal hyperplasia, which is overproduction of cortisol that leads to hypertension 
and hyperaldosteronism (Zachmann et al. 1983). 
3.6. Steroids and their receptors 
Steroids are important biological compounds which mediate a wide range of physiological 
processes such as cellular differentiation and proliferation, control of metabolism and 
immunity, development of sexual characteristics, muscle and bone synthesis, maintenance of 
water and salt concentration as well as control of reproductive system. There are five classes 
of steroids recognised in mammals: mineralocorticoids, glucocorticoids, androgens, estrogens 
and progestagens. In this section, only mineralocorticoids, glucocorticoids, and androgens are 
discussed. The mineralocorticoids are important as they maintain water and mineral balance. 
The glucocorticoids regulate the metabolism of carbohydrates, lipids, and proteins while the 
androgens play a vital role in sexual development and growth. 
The adrenal cortex zones are the primary steroidogenic sites where mineralocorticoids, 
glucocorticoids, and androgens are biosynthesised. Adrenal steroids are all biosynthesised 
from cholesterol via sequential cytochrome P450 steroid hydroxylases and 3EHSD catalysed 
reactions (known as steroidogenesis) (Li et al. 2004). Steroids are lipid soluble and thus pass 
through the lipid membranes by diffusion out of and into the blood stream. In the cytoplasm, 
steroids bind to their respective receptors in the cytoplasm or nucleus to form steroid-receptor 
complexes (White 1994).  
Glucocorticoid receptors and androgen receptors not in a steroid-receptor complex, are 
mostly found in the cytoplasm, and translocate to the nucleus only after forming a steroid-
receptor complex. The mineralocorticoid receptor is found in both the cytoplasm and nucleus 
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when not in a steroid-receptor complex, but only found in the nucleus when complexed to a 
steroid (Tyagi et al. 2000). Steroid receptors travel to and from cellular compartments as they 
mature to exert their biological effects. The receptors are associated with chaperone and co-
chaperone proteins in the absence of steroids. Receptors act as ligand-dependent transcription 
factors that regulate various genes in the presence of their respective steroids (Echeverria & 
Picard 2010). Chaperones are important for the maintenance of the receptors in an active and 
steroid responsive form, and dissociate from the receptor when a specific steroid binds (Pratt 
et al. 2004; Echeverria & Picard 2010). Chaperones and co-chaperones (Hsp90 and Hsp70 
respectively) are proteins that prevent protein aggregation of steroid receptors (Zuehlke & 
Johnson 2011).  
Some steroids (see L in Figure 3.10) elicit their effects when they diffuse into the cytoplasm, 
where they bind to a specific steroid receptor (glucocorticoid, mineralocorticoid, or androgen 
receptor) that is associated with the chaperone. Upon binding, the steroid-receptor complex 
dissociates from the chaperones, undergoes conformational change, and moves to the 
nucleus. The receptor part of the steroid-receptor complex binds to the steroid response 
element on the DNA which induces target gene activation by transactivation or trans-
repression, see Figure 3.10. The mineralocorticoid steroid mechanism of eliciting its effect is 
similar to the glucocorticoid steroid mechanism (Pratt et al. 2004) . 
 
Figure 3.10 Representation of gene activation via the steroid receptor (SR) upon ligand (L) binding. 
Heat shock proteins (HSP), hormone response element (HRE). 
3.6.1. Mineralocorticoids 
Mineralocorticoids are produced in the zona glomerulosa (Xing et al. 2011). A number of 
factors regulate the biosynthesis of the primary mineralocorticoid, ALDO. Principally 
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production of ALDO is regulated by Ang II, ATCH and a decrease in sodium levels and an 
increase in potassium levels in the blood (Pascual-Le Tallec & Lombès 2005). The other 
active mineralocorticoids are DOC, CORT and 18OH-CORT, but are considered weak 
mineralocorticoids because their known potencies are lower than ALDO (Kazuhiko et al. 
1987). Mineralocorticoids regulate fluid and salt balance by inducing reabsorption of sodium 
ions and excretion of potassium ions, mostly in the kidneys and colon. ALDO is responsible 
for maintaining acid-base balance by inducing reabsorbtion of the H
+
 ions in the collecting 
duct, resulting in urine acidification (Good 2007). The mineralocorticoids have been shown 
to stimulate synthesis of cardiac collagen and proliferation of fibroblast in the heart 
(Padmanabhan et al. 2000). 
Cortisol, a glucocorticoid, has been reported to also bind and activate the mineralocorticoid 
receptor. Though the mineralocorticoid and glucocorticoid receptors display close structural 
and functional similarities, ALDO is selective for the mineralocorticoid receptor only 
(Pascual-Le Tallec & Lombès 2005). Cortisol and ALDO bind to the mineralocorticoid 
receptor with similar affinities  but their dissociation kinetics differ, where that of ALDO is 
slower showing that ALDO-receptor complexes are more stable than cortisol-receptor 
complexes (Lombes et al. 1994). The dehydrogenase enzyme, 11βHSD type 2, protects  the 
mineralocorticoid receptor from cortisol binding. This enzyme catalyses the conversion of 
cortisol and CORT to their inactive metabolites, cortisone and 11-dehydrocorticosterone (11-
DHC), in humans and rodents respectively. The enzyme is expressed in the colon and kidney 
which are mineralocorticoid target tissues. Impaired activity of this enzyme results in sodium 
retention (Stewart et al. 1996). 
 Clinical conditions, such as hypertension, have been linked with high concentrations of 
ALDO. CYP11B2 deficiency, due to mutations, lead to salt wasting and hypotension 
(Padmanabhan et al. 2000). Competitive inhibitors of angiotensin-converting enzyme (ACE), 
such as enalapril, and mineralocorticoid receptor inhibitors, such as spironolactone, have 
been used for the treatment of hypertension. Inhibitors that directly inhibit some of the P450 
enzymes that synthesise ALDO are still being investigated (Abrams et al. 1984; Sturrock et 
al. 2004; Calhoun et al. 2011).  
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3.6.2. Glucocorticoids 
Biosynthesis of glucocorticoids occurs in the zona fasciculata of the adrenal cortex. 
Glucocorticoids are considered to be stress hormones since their secretion is altered stress 
factors (Huizenga et al. 1998; Chrousos & Gold 1998). Secretion of glucocorticoids is 
controlled by the HPA axis in response to various physiological and physical stress factors. 
Secretion from the adrenals occurs in a pulsatile ultradian rhythm. The main glucocorticoid is 
cortisol in humans and CORT in rodents. Glucocorticoids derive their name from one of their 
functional roles in the body, which is the stimulation of glucose metabolism (Talabér et al. 
2013).  
Glucocorticoids are steroids that control transcription of many genes that affect a number of 
important metabolic and inflammatory reactions. They are responsible for increasing the 
blood glucose levels by coordinately controlling the expression of genes involved in amino 
acid degradation, ammonia detoxification and gluconeogenesis. Glucocorticoids induce the 
expression of anti-inflammatory proteins (cytokines) and suppress expression of pro-
inflammatory proteins (Rhen & Cidlowski 2005; Permissive & Munck 2000). The 
importance of glucocorticoids is reflected in the inability of humans to survive without them. 
Abnormal glucocorticoid production, such as a cortisol deficiency due to adrenal 
insufficiency, leads to weight loss, tiredness, weakness and impaired regulation of blood 
glucose levels (Stewart et al. 1993).  
Chronic stress results in elevated cortisol levels which have been associated with clinical 
conditions such as hypertension, metabolic syndrome cardiovascular diseases, 
hyperglycemia, suppressed immunological responses and monocyte differentiation into 
macrophages (Elenkov & Chrousos 2002). Patients suffering from connective tissue 
disorders, bullous diseases, and other dermatological conditions, are treated with systematic 
long-term courses of glucocorticoids. However, it has been shown that long-term 
glucocorticoid therapy causes adverse results in bone turnover, lung differentiation, cell 
growth, and proliferation during wound healing. Also glucocorticoid therapy affects the HPA 
axis as it reduces the  hormone levels of sex steroids (Curtiss Jr et al. 1954). Therefore 
maintaining normal glucocorticoid levels is critical to the endocrine function. 
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3.6.3. Androgens 
Androgens, C19 steroids, are produced in the zona reticularis of the adrenal cortex. DHEA is 
a pre-androgen that is secreted in the ovaries and adrenals in women before menopause. The 
zona reticularis expresses large amounts of CYP17A1, which in turn results in large amounts 
of DHEA. The DHEA is subsequently converted to A4 and DHEAS through sulphonation. 
The DHEAS and A4 are precursors for the production of the sex steroids testosterone and 
estrogen in women. DHEA and DHEAS are high circulating androgens but are weak 
androgens as they have a lower affinity for the androgen receptor than testosterone. 
Testosterone, a potent androgen, is biosynthesised in small amounts (Handa & Price Jr 2000). 
Levels of sex steroids are controlled by the expression of other steroidogenic and 
metabolising enzymes which determine the conversion of DHEA to potent sex steroids in 
each tissue type. This allows for local steroid hormone activity as the steroids do not diffuse 
out of the tissues into the blood circulation, thus reducing side effects on other tissues 
(Panjari & Davis 2010).  
The use of these adrenal androgens is not well understood. It is reported that their increase is 
linked to the development of secondary sex traits such as pubic hair and contribute to some of 
the body changes at an early age (Idkowiak et al. 2011). DHEA deficiency is usually a result 
of clinical conditions such as Addison’s disease which inhibit adrenal steroid synthesis which 
is treated by DHEA replacement therapy (Buvat 2003).  
3.7. Regulation of steroidogenesis 
Regulation of steroidogenesis depends on hormones produced primarily by the neuro-
endocrine system. Regulation of steroid biosynthesis is important as the steroids are not 
stored in the body but rather produced when needed (Dickerman et al. 1984). To maintain the 
complex hormonal systems, there are complex mechanisms which regulate hormone release 
to maintain homeostasis. A series of positive and negative feedback activities exist for these 
systems. The HPA axis and the RAAS are well known regulatory mechanisms that incur 
negative and positive feedback when necessary. The regulation can be acute or chronic where 
acute response occurs within minutes from ACTH, Ang II and potassium ion stimulation. 
This stimulation results in the mobilisation of cholesterol for streoidogenesis. The circulating 
ACTH, Ang II and potassium ion concentrations influence the capacity of adrenal 
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steroidogenesis, where glucocorticoid, mineralocorticoid and androgen biosynthesis is 
regulated (Li et al. 2004). Chronic responses can take hours and involves transcription and 
expression of steroidogenic enzymes (Clark et al. 1995). Unregulated steroid biosynthesis can 
lead to adverse clinical conditions such as hypertension, kidney failure, heart diseases and 
many more. 
ACTH and Ang II are the primary effectors of adrenal cortex steroidogenesis where ACTH 
plays a major role in the HPA axis and Ang II plays a major role in RAAS.  Regulation of 
steroidogenesis occurs in different ways which include inhibition or stimulation of enzyme 
expression. The peptide hormone, ACTH, has been reported to have the ability to regulate 
P450c11 gene expression as it stimulates CYP11B1 transcription, a process that can take 
hours (Arola et al. 1994). Moreover, in the long term, ACTH inhibits gene expression of 
CYP11B2 and thus subsequently inhibits ALDO synthesis (Aguilera et al. 1996). Some 
studies have shown that ACTH eliminates intermediates for ALDO biosynthesis by 
increasing the expression of CYP17A1 and CY11B1 that produce cortisol. The zona 
glomerulosa maintains CYP11B2 gene expression under normal ATCH circulating levels. 
This is due to Ang II inhibiting ACTH’s stimulating effects on the zona glomerulosa and not 
on the zona fasciculata (Begeot et al. 1988). Proliferation of zona fasciculata cells and 
transformation of zona glomerulosa to zona fasciculata cells has been reported to be induced 
by ACTH (Arola et al. 1988). The regulatory mechanisms (HPA axis and RAAS) are 
discussed in the following sections. 
3.7.1. Hypothalamic–pituitary–adrenal axis  
The HPA axis (Figure 3.11) is a complex regulatory system which integrates the endocrine 
system and the neuronal systems. The integration of the two systems makes the HPA system 
important as it affects the immune system and the central nervous system (Watson & Mackin 
2006). The system consists of the hypothalamus, the pituitary and the adrenal gland. The 
HPA axis, as explained earlier in section 3.1, is controlled by secretion of CRH and AVP 
hormone from the hypothalamus, the primary gland. The secretion is initiated by internal or 
external physiological stimuli, which are detected by the nervous system. The physiological 
stimuli, which can be referred to as stressors, can be a drop in glucose plasma levels, or 
abnormal body temperature (Munch 1971).  
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CRH and AVP act together to stimulate production and secretion of ACTH by the anterior 
pituitary gland. The CRH has been reported to be only active in acute stress while AVP is 
important for the maintenance of the HPA axis during chronic stress (Lightman 1994; Bonaz 
& Rivest 2004). AVP cannot function on its own as it is a weak ACTH release stimulant but 
has been reported to aid CRH to stimulate ACTH secretion (Liu et al. 2004). AVP also has 
been reported to stimulate re-uptake of water by the kidneys as it increases the permeability 
of the collecting ducts (Vander et al. 2004).  
The hypothalamus and the anterior pituitary gland are connected together by a vascular 
system. The vascular system ensures blood flow from the hypothalamus to the pituitary gland 
thus CRH and AVP are transported to the pituitary gland (Vander et al. 2004). The anterior 
pituitary gland secretes ACTH directly into the main blood stream to be transported to the 
adrenal cortex. At the adrenal cortex, ACTH stimulates steroidogenesis, particularly 
glucocorticoid synthesis, by binding to the ACTH receptors on the cell membranes of the 
adrenal cortex. The HPA axis help to maintain constant glucose levels in the body. 
The HPA axis is self-controlled by unbound glucocorticoids in the blood stream to reduce 
fluctuations of glucocorticoids, this is referred to as the negative feedback mechanism (Figure 
3.11). The unbound glucocorticoids act on the central nervous system, the hypothalamus and 
the pituitary gland thus inhibiting synthesis and secretion of CRH and ACTH (Meyer et al. 
1998). 
 
Figure 3.11. Representation of the hypothalamus-pituitary-adrenal axis and its negative feedback 
mechanism. Reproduced and adapted from (Mitrovic 2002) 
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3.7.2. Renin-angiotensin–aldosterone system  
The RAAS (see Figure 3.12) is a system that is important for the regulation of 
steroidogenesis in the adrenal cortex, particularly ALDO biosynthesis. Maintaining blood 
pressure and intravascular fluid volume is the main function of the RAAS. The system 
consists of renin, an aspartyl proteolytic enzyme produced for its precursor, prorenin. 
Prorenin is cleaved to renin in the renal afferent arteriole juxtaglomelur cells of the kidneys. 
Renin secretion is stimulated by reduced perfusion blood pressure in the afferent arteriole 
which is sensed by baroreceptors. Biosynthesis of renin is inhibited by increased renal 
perfusion blood pressure and increased circulation of Ang II (Urata et al. 1990; Bock et al. 
1992). High blood plasma levels of K
+ 
stimulate ALDO biosynthesis and secretion and 
suppress  renin’s  activity.  High  salt  concentrations  in  distal  tubules  of  the  kidney  increase 
vasoconstriction of the afferent arteriole and decrease renin release, which consequently leads 
to decreased ALDO biosynthesis (Harrison-bernard 2009).  
Low blood pressure could be a result of loss of water from the blood or low concentrations of 
salts namely sodium (Na
+
) and potassium (K
+
). Secretion of renin is the rate-limiting step of 
RAAS and responds to decrease in renal blood pressure and salt content. Renin cleaves 
hepatic angiotensinogen to Angiotensin I (Ang I) in the liver. Ang I (which is inactive) is 
primarily converted into Ang II in the lungs by ACE (Zaman et al. 2002; Wu et al. 2010). 
Ang I can be converted to Ang II by protease chymase, a chymotrypsin-like protease (Urata 
et al. 1990). 
Ang II, a peptide, forms an important part of the system, as it stimulates the adrenal cortex to 
produce steroids, in particular mineralocorticoids. The peptide Ang II can be locally produced 
by various tissues in the body, including the heart, which could be  responsible for the 
chronic maintenance of cardiovascular homeostasis (Engelia et al. 2003; McMurray et al. 
2010). Ang II activates the Ang II type 1 receptor (AT1) which causes vasoconstriction and 
raises blood pressure (Figure 3.12). Ang II binds to the AT1 receptors on the adrenal cortex, 
preferably on the zona glomerulosa, to elicit ALDO production and secretion (Ehrhart-
Bornstein et al. 1998; Briet & Schiffrin 2010). The main mineralocorticoid, ALDO, in turn, 
elicits a series of reactions via mineralocorticoid receptor activation to restore normal water 
and salt balance. ALDO increases renal reabsorption of water and Na
+
 (via the epithelial 
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sodium channel) while stimulating the elimination of potassium in the kidney. Therefore 
ALDO helps to maintain blood pressure and volume to vital organs (Carpenter et al. 1961). 
Plasma concentrations of Ang II, Na
+
 and K
+
 are the key factors that stimulate RAAS activity 
(Ehrhart-Bornstein et al. 1998). Low blood plasma levels of Na
+
, probably due to a low Na
+
 
diet, stimulate an increase in renin and ALDO plasma concentration (Takagi et al. 1988).  
 
Figure 3.12. Schematic representation of RAAS and its inhibitors. (Sayer & Bhat 2014). 
High blood pressure (hypertension), kidney diseases, and cardiovascular diseases have been 
found to be assorciated with the malfunction of RAAS. Malfunction of RAAS could be due 
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to overproduction or underproduction of renin or Ang II or ALDO which leads to clinical 
disorders. A study conducted by Bird et al. (1992) in ovine adrenal cells showed that Ang II 
stimulate production of ALDO and not cortisol by suppressing CYP17A1 expression and 
rendering the adrenocortical cells irresponsive to ACTH. This study showed that Ang II has 
the ability to inhibit glucocorticoid secretion (Bird et al. 1992). Results of another 
investigation carried out in human adrenocortical cells showed that Ang II stimulation, not 
only resulted in ALDO secretion but in cortisol secretion (Bird et al. 1992). 
Currently inhibitors such as ACE inhibitors (lisinopril, captopril), renin inhibitors (aliskerin) 
and mineralocorticoid antagonist (spironolactone, eplerenone) are used to treat high blood 
pressure (see Figure 3.12). It has been reported that weight loss in humans decrease the 
circulating concentration of angiotensinogen, plasma renin, and ALDO (Engeli et al. 2005; 
Dall’Astaa et al. 2009). Therefore maintaining a healthy life style is vital for the prevention 
of hypertension. Usage of the ACE inhibitors mentioned earlier has side effects such as 
impotence, gynaecosmastia, breast tenderness, and menstrual irregularities. These drugs 
interfere with PROG and androgen receptors hence there is a need to develop a drug that has 
fewer side effects or none at all (Menard 2004). 
Regulation of androgen synthesis is not well known, although the results of some studies 
indicate that the zona fasciculata and reticularis preferentially regulate expression of 
CYP17A1  and  CYP11A1  together  with  3βHSD  and  cytochrome  b5. These enzymes 
ultimately control and determine androgen production (Rainey & Nakamura 2008). ACTH 
also stimulates androgen production but there are additional unknown mechanisms 
responsible for the regulation of androgen production. ACTH adrenal stimulation has 
sensitive negative feedback control via the effect on CRH production by cortisol only and for 
androgens it is unknown what effect it has (McKenna et al. 1997). 
3.8. Inhibition of P450 enzymes 
P450 enzymes are important enzymes because of the number of metabolic functions they 
exhibit, as discussed in the earlier sections. These enzymes are involved in detoxification of 
chemical compounds and drugs that might otherwise cause adverse effects, such as cancer, 
allergies or intolerance reactions. Drugs interact with the enzymes either by being 
metabolised or inhibited. The role of P450s in bio activation, and metabolism of drugs 
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leading to prevention and treatment of ailments such as tumor formation, has made these 
enzymes targets for drug treatments (Baston & Leroux 2007). 
Inhibitors are drugs that block the activity of one or more metabolic activities of enzymes and 
the degree of inhibition depends on the ability of the inhibitor to bind to the active site of the 
enzyme or  the  inhibitor’s concentration. A single P450 enzyme can metabolise a particular 
drug and, simultaneously, be inhibited by that particular drug. On the other hand, a drug can 
be metabolised by one P450 enzyme and inhibit another enzyme. Inhibition is usually 
immediate unlike induction of enzyme activity that takes time (Lynch & Price 2007). 
P450 inhibition is categorised as reversible, quasi reversible and irreversible. Reversible is 
the most common and documented type of drug interaction. Reversible inhibition only shows 
dose-dependent inhibition kinetically. Normal metabolic activities of the reversibly inhibited 
enzymes resume after elimination of the inhibitor in the body. Reversible inhibition is divided 
into competitive and non-competitive inhibition: where competitive inhibition entails the 
inhibitor preventing binding of the substrate to the active site while non-competitive binding 
is when the inhibitor does not affect substrate binding as it binds to another site that is not the 
active site (Lin & Lu 2001).  
Quasireversible inhibition is when a stable, non-covalent and tight metabolic intermediate 
P450 complex is formed. The complex does not destroy the enzyme but the enzyme will be 
unavailable for any other metabolic activities. Unlike in in vivo conditions, the metabolic 
complex formed is considered irreversible in in vitro conditions. Irreversible inhibition is 
when the enzyme is inactivated or destroyed by the inhibitor due to the covalent binding of 
the reactive intermediate to the heme of the P450 active site. Irreversible inhibition only 
shows dose-dependent and time-dependent inhibition kinetically. In order to correct the 
quasireversible and the irreversible inhibition in vivo, new enzymes will have to be 
synthesized (Lin & Lu 2001). 
Non-steroidal compounds, which are compounds that inhibit enzymes through reversible 
competitive inhibition, are now being used as P450 inhibitors as they do not cause unwanted 
side effects. Steroidal compounds have affinity towards one or more SRs acting as 
antagonists or agonists, thus they are not specific and result in adverse side-effects (Baston & 
Leroux 2007). The non-steroidal inhibitors have a sterically non-hindered heteroatom in their 
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structure which controls the heme and they have hydrophilic groups that mimic the natural 
substrate of enzymes. For instance, a non-sterodial inhibitor, Fadrozole, used to inhibit 
aromatase, is selective and more potent and influences both ALDO and CORT synthesis. 
Side-effects are avoided when the inhibitor is sufficiently specific not to induce unnecessary 
steroid biosynthesis of other steroids (Baston & Leroux 2007).  
3.9. Conclusion 
The adrenal gland is an important organ of the body that is part of the network that controls 
homeostasis. It is involved in steroidogenesis, which is a complex and vital process in 
mammals. Steroidogenesis yields steroids responsible for maintaining homeostasis and is 
regulated by various complex mechanisms. Cholesterol, the main substrate for 
steroidogenesis, is converted to various steroids. Cytochrome P450 enzymes together with 
dehydrogenases  catalyse  the  production  of  steroidogenesis. The  enzymes’  catalytic  activity 
determines the steroid output. Investigating the homology and activity of P450 enzymes has 
become important because these enzymes are not only involved in steroid biosynthesis but 
also drug metabolism. P450 enzymes’ catalytic activity depends on the electron donors they 
are involved with and they have been categorised according to where their electron donors 
are localised (mitochondria and microsomal P450 enzymes). The mitochondrial and 
microsomal enzymes produce different steroids and they are dependent on each other. The 
RAAS and the HPA axis are important for the regulation of steroidogenesis as they control 
steroid production by controlling steroidogenic enzymes expression in the adrenal. 
Understanding the regulation of their expression, activity, and inhibition mechanisms is 
important for pharmaceutical reasons. 
P450 enzymes, like any other enzymes, are specific to their endogenous substrates; therefore 
their inhibitors could be chemically or structurally similar to their endogenous substrates. The 
inhibitors will bind to the active site or to another pocket on the enzyme and cause a 
conformational change like the substrate would do. Available P450 enzyme inhibitors 
currently used to alleviate endocrine related diseases are competitive inhibitors and they 
inhibit P450 steroid biosynthesis activity. These drugs have been found not to be specific for 
the enzyme they are supposed to inhibit but interfere with the activity of other P450 enzymes 
and other enzymes triggering toxicological effects and unwanted side-effects. Drugs, such as 
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spironolactone, interfere with PROG and androgen binding to their respective receptors thus 
causing sexual undesirable effects (Menard 2004). These effects have led to the need to find 
drugs or compounds that can be used to inhibit the activity of P450 enzymes without causing 
unwanted side-effects.  
To date, there has not been a drug that has been approved for human usage that can 
specifically inhibit CYP11B2 which produces ALDO. A drug, LC1699, has been reported to 
decrease ALDO tissue and plasma concentration in primary aldosteronism. The drug was 
tested on patients with primary aldosteronism and it was shown that at a concentration of 0.5-
1 mg, there was a dose-dependent reversible suppression of plasma and urinary ALDO 
concentration by 70-80 %. In the same study it was also noted that there was a dose-
dependent increase of Ang II and deoxycortisol concentration; thus this drug was not 
approved for human use as  it  inhibited other enzymes’ activities, such as  that of CYP11B1 
(Amar et al. 2010; Calhoun et al. 2011). 
Chapters 4 and 5 report the effect of Rooibos extract on microsomal and mitochondrial P450 
enzymes particularly CYP17A1, CYP21A2, CYP11B1, and CYP11B2. Chapter 5 also 
reports on investigations into the influence of Rooibos on the steroid output of H295R cells. 
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CHAPTER 4 
The influence of Rooibos (Aspalathus linearis) on adrenal cytochrome P450 
enzymes 
4.1 Introduction 
Cytochrome P450 enzymes are primarily responsible for detoxification, biotransformation 
and the removal of foreign compounds (xenobiotics) in mammals. In addition, P450-
dependent enzymes are also involved in the biosynthesis of steroid hormones, which are 
important for the endocrine system, as discussed in Chapter 3. Although each steroidogenic 
enzyme can catalyse multiple reactions, often with different steroid substrates, these P450-
dependent enzymes are highly specific to the steroid biosynthetic pathways (Estabrook 2005). 
As discussed earlier, the arrangement of the heme pigment in the active site of cytochrome 
P450-dependent enzymes bestows unique spectral properties on these hemoproteins. The 
binding of substrates and inhibitors to P450-dependent enzymes can thus be studied using 
difference spectroscopy, as discussed in section 4.2.6.1.  
Rooibos, which is a good dietary source of flavonoids, is anecdotally reported to alleviate a 
variety of endocrine-related diseases, such as stress, hypertension, anxiety, depression and 
diabetes (Persson 2012; Schloms et al. 2013). Scientifically based assays, however, are 
needed to validate the anecdotal reports of Rooibos alleviating endocrine-related diseases. 
Most of the endocrine-related diseases are characterised by elevated levels of a particular 
steroid synthesised in the adrenal gland by the P450 enzymes. It is possible that Rooibos can 
modulate adrenal steroidogenesis, thus influencing the production of steroids in the adrenal, 
as it contains polyphenols that have been reported to affect steroidogenesis in H295R cells 
(Schloms et al. 2012; Hasegawa et al. 2013). Rooibos, and some flavonoids found in 
Rooibos, have been reported by Schloms et al. (2012) to affect adrenal cytochrome P450 
enzymes in H295R cells, and in transfected COS-1 cells. The usage of reliable scientifically 
based assays, however, is necessary to validate the anecdotal reports of Rooibos alleviating 
endocrine-related diseases.  
In this study, the effect of Rooibos (unfermented and fermented), and the flavonoids 
aspalathin, rutin and quercetin, on the binding of natural substrates (PROG and DOC) to 
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adrenal P450-dependent enzymes was investigated. DOC is a natural substrate of CYP11B1 
and CYP11B2, while PROG is a natural substrate of CYP17A1 and CYP21A2. These 
enzymes play crucial roles in the biosynthesis of ALDO and cortisol, which are steroids that 
are important for the maintenance of homeostasis in the body, as mentioned earlier in section 
3.6 of Chapter 3.  
4.1.1 Methodology 
The investigation employed the unique spectral properties of the P450-dependent enzymes by 
performing spectral substrate binding assays. The binding of PROG and DOC to microsomal 
and mitochondrial P450 enzymes was investigated in ovine adrenal preparations in the 
presence of the Rooibos extracts or selected flavonoids. 
4.2. Materials and methods 
4.2.1 Reagents 
Dried unfermented and fermented Rooibos was provided by the South African Rooibos 
Council. Fermented and unfermented Rooibos are products of the Rooibos plant, obtained 
after harsh and mild processing conditions respectively. These conditions are oxidative and 
affect the flavonoid content of Rooibos (Joubert et al. 2008). The selected flavonoids 
(aspalathin, rutin and quercetin) and steroids (PROG and DOC) were purchased from Sigma 
Chemical Co (South Africa). Sheep adrenals were obtained from Tomis Abattoir in Hermon, 
Western Cape, South Africa. The adrenals were surgically removed and covered in ice 
immediately after removal. NADPH and sodium dithionate were purchased from Roche 
Diagnostic (South Africa). Pierce BCA
TM
 protein determination kits were purchased from 
Pierce (Rockford, IL, USA). A Varian Cary 100 double-beam UV-Vis spectrophotometer 
was used to record the changes in wavelengths in the presence and absence of Rooibos 
extracts. 
4.2.2. Preparation of unfermented and fermented Rooibos extracts. 
Methanolic extracts of Rooibos were prepared by placing 20 g dried Rooibos plant material 
in a glass soxhlet extractor. The extractor was fitted with a double walled condenser and 
placed on a round bottom flask containing 200 mL of chloroform. The extraction was done in 
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an air extraction hood for 8 hr at ± 60 ºC on a heating mantle. The chloroform phase was 
discarded after 8 hr and replaced with 200 mL of methanol for an additional 8 hr. During the 
time of extraction, the entire extraction setup was covered in aluminium foil to protect the 
flavonoids in the Rooibos against light degradation. The final extract of rooibos was removed 
and dried on a rotary evaporator under reduced pressure at 37 ºC. During the release of the 
vacuum from the dried extract, nitrogen gas was introduced to minimise oxidation. The round 
bottom flask was weighed before and after the extraction to obtain the mass of the Rooibos 
extract. The measured Rooibos extract was redissolved in deionised water to make a final 
concentration of 100 mg/mL and clarified by centrifugation at 6000 xg for 5 min. Aliquots (1 
mL), prepared from the supernatant, were stored at -20 qC in dark conditions to avoid any 
compositional changes. Extractions were repeated for both the unfermented and fermented 
Rooibos. The Agricultural Research Council subsequently analysed the unfermented and 
fermented Rooibos extracts for flavonoid content using high-performance liquid 
chromatography with photodiode array detection (HPLC-DAD) method, as previously 
published by Beelders et al. (2004). 
4.2.3 Preparation of ovine adrenal mitochondria and microsomes. 
Ovine mitochondrial and microsomal preparations were obtained by differential 
centrifugation of chilled surgically removed adrenals from slaughtered ovine according to the 
method described by Yang and Cederbaum (1994). All procedures were performed in a 
temperature controlled room at 4 °C. The adrenals were defatted and decapsulated using a 
scalpel and washed with a 15 mM KCl solution. The adrenal tissue (101.09 g) was 
homogenised in 300 mL 10 mM Tris-HCl buffer (pH 7.4), Buffer A, using a Potter-Elvejhem 
glass homogeniser. Buffer A contained 0.25 M sucrose and 1 mM EDTA. The homogenate 
was centrifuged for 15 min at 12 000 xg at 4 ºC to acquire a pellet, which contained the 
mitochondria, and the supernatant, which contained the microsomes.  
The preparation of the mitochondria and microsomes is shown schematically in Figure 4.1. 
The mitochondrial pellet was resuspended in 200 mL of 10 mM Tris-HCl buffer (pH 7.4), 
Buffer C. Buffer C contained 1 mM EDTA, 0.25 M sucrose and 1 % bovine serum albumin 
(BSA) mixture. Buffer C subsequently was used to homogenise and centrifuge the 
mitochondrial pellet at 12000 x g for 15 min at 4 ºC. The supernatant was discarded and the 
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resulting pellet was resuspended in 200 mL of 10 mM Tris-HCl buffer (pH 7.4), Buffer B. 
Buffer B contained 150 mM KCl and 1 mM EDTA and was used to wash and homogenise 
the pellet, which subsequently was centrifuged at 12000 xg for 15 min at 4 ºC. The resulting 
supernatant was discarded. This washing procedure was repeated twice to remove fat and 
blood. The washed mitochondrial pellet was lyophilised overnight. To remove excess fat 
from the dried mitochondrial pellet, pure filtered dry acetone was used to suspend, 
homogenise and centrifuge the dry pellet at 12000 xg for 10 min at 4 ºC. The defatted 
mitochondrial pellet was lyophilised overnight. The dry mitochondrial preparation was stored 
at -20 °C for future use.  
The microsomal preparation was prepared by slowly stirring PEG 8000 (50 % w/v) into the 
supernatant containing the microsomes to a final concentration of 8.5 %. The mixture was 
stirred for 10 min and then centrifuged at 13000 xg for 20 min. The supernatant was 
discarded and the microsomal pellet was resuspended in 10 mL of Buffer B. This step was 
repeated until the supernatant was clear (at least three times). The final microsomal pellet was 
resuspended in 15 mL of Buffer A. The suspension was stored at -80 °C in 1 mL aliquots for 
future use.  
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Figure 4.1. Flow diagram showing the preparation of ovine mitochondrial and microsomal 
preparations. 
4.2.4 Determination of cytochrome P450 concentration 
The cytochrome P450 content of the adrenal mitochondrial and microsomal preparations was 
determined from a type II difference spectrum using the carbon monoxide (CO) method as 
described by Omura and Sato (1964). The spectrum was allowed to develop fully for at least 
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5 min, as the reduction of the CO cytochrome P450 by sodium dithionite (a strong reducing 
agent) elicits a slow reaction. For this investigation, the mitochondria powder (2 mg/mL) was 
resuspended in 0.1 M phosphate buffer (pH 7.4) containing 10 % ethylene glycol. The 
mitochondrial suspension was sonicated on ice for 5 min at one-min intervals. To determine 
the microsomal P450 concentration, the microsomal preparation was diluted at a ratio of 1:3 
of microsomal preparation and Buffer A. 
The 4 mL mitochondrial preparation sonicate was saturated with carbon monoxide, and 1.5 
mL of the saturated sonicate was subsequently added to each of two optically matched quartz 
cuvettes, the sample and reference cuvette respectively. A baseline was recorded between 400 
and 500 nm. Sodium dithionate (~2 μg) was subsequently added to the sample cuvette alone 
and the contents were mixed by gentle inversion. The reference cuvette was also mixed by 
gentle inversion to ensure homogeneity. The spectrum was recorded between 400 and 500 nm 
after 10 min. The mitochondrial sonicate in the reference cuvette served as a baseline for the 
experiment. The same procedure was carried out for the microsomal preparations. The 
cytochrome P450 concentration (C) of the preparations was determined using the Beer-
Lambert law presented in Eq. 4.1. 
ΔAbs = ɛCl                       (Eq. 4.1) 
where  the  ∆Abs  is  the  difference  in  absorbance  between  450  nm  and  500  nm,  the molar 
extinction coefficient  (ε) = 91 cm-1 mM-1, and l is the path length through the solution (1 
cm) as described by Omura and Sato (1994). 
4.2.5 Protein determination 
A Pierce BCA
TM
 protein assay kit was used to determine the protein concentration of the 
preparations. Phosphate buffer (1 mM) was used as a blank and for the dilution of the 
samples. A series of standard protein concentrations was prepared: 0.25, 125, 250, 500, 750, 
1 000, 1 500 and 2 000 μg/mL of the BSA in 1 mM phosphate buffer. Working reagent was 
mixed  according  to  the manufacturer’s  protocol. Only  200 μL of  the working  reagent was 
used per well, containing  only  10  μL  of  the  mitochondrial  sonicate  or  10  μL  of  the 
microsomal dilution or 10 μL of each standard sample in a 96-well micro titre plate. The plate 
was incubated at 37 °C for 30 min in order to obtain the visible colour, and absorbance was 
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recorded at 545 nm. The protein determination was carried out in triplicate. A standard curve 
was constructed from the standard sample results and was used to determine the protein 
concentration. 
4.2.6. Bioactivity in spectral binding assay 
PROG was used as substrate for the microsomal P450 enzymes, whereas DOC was used as 
substrate for the mitochondrial P450 enzymes. The substrates were used at saturating 
concentrations  of  13  μM  and  12  μM  for  PROG and DOC respectively. To investigate the 
interference of Rooibos or selected flavonoids on the binding of the substrates to the 
respective P450 enzymes, varying concentrations of Rooibos extracts and flavonoids were 
used. The selected flavonoids were dissolved in ethanol.  
4.2.6.1. Substrate-induced difference spectra 
The interaction of the Rooibos extracts with the P450 enzymes was investigated at room 
temperature using UV-Vis spectroscopy. The binding of PROG to CYP17A1 and CYP21A2 
in a microsomal preparation, and the binding of DOC to CYP11B1 and CYP11B2 in a 
mitochondrial preparation, were assayed in the presence of the different concentrations of 
unfermented and fermented Rooibos extracts. A similar investigation was carried out using 
different concentrations of the selected flavonoids dissolved in ethanol. The microsomal 
preparation was pipetted into two optically matched quartz cuvettes to record a baseline 
absorbance. The two quartz cuvettes represent the reference and the sample.  
For the microsomal P450 substrate binding investigation, PROG, dissolved in ethanol, and 
ethanol were added to the sample and reference cuvettes respectively at equal volumes, in the 
presence of Rooibos extracts or flavonoids. The cuvettes were gently inverted and a 
substrate-induced difference spectrum was recorded. To investigate the percentage inhibition, 
different concentrations of Rooibos extracts and flavonoids were used. Compound 
interference with PROG binding to P450 enzymes in microsomal preparation was indicated 
by a reduction in the amplitude of the peak and trough of the type I difference spectrum (see 
Figure 4.2). The interference is illustrated by the decrease in the absorbance maximum at 390 
nm and an increase in the absorbance minimum at 420 nm when compared to the substrate-
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induced difference spectra produced in the absence of the compounds. A similar investigation 
was also carried out for DOC binding to P450 enzymes in mitochondrial preparations.  
 
Figure 4.2. Example of type I substrate-induced  difference  spectra.  PROG  (13  μM)  was  used  as 
substrate binding to ovine microsomal P450 enzymes in the absence and presence of rutin (26 μM). 
The P450 concentration was 0.5 nmol/mg protein. 
The interaction of the compounds with the P450 enzymes was expressed in percentage 
inhibition, as shown below: 
% Inhibition = 100 – ((I/C) X 100)                         (Eq. 4.2) 
where I = absorbance at 390 nm minus absorbance at 420 nm in the presence of inhibitor, and 
C = absorbance at 390 nm minus absorbance at 420 nm in the absence of inhibitor. 
4.2.7. Statistical analysis 
Statistical analyses were performed using GraphPad Prism Version 5.0 for Windows 
(GraphPad Software), San Diego, California, USA. Binding assays were expressed as the 
mean, with error bars representing the standard error of the mean (SEM). Statistics of the 
binding assays were calculated by a one-way ANOVA, followed by a Dunnett’s multiple 
comparison test. Values of P < 0.05 and values of P < 0.0001 of one-way ANOVA and 
Dunnett’s multiple comparison test respectively were considered to be statistically 
significant. Protein concentration analyses were done using Microsoft® Excel 2003, based on 
a standard curve, in which case the results were expressed as μg protein/mL. 
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4.3. Results  
4.3.1 Analysis of Rooibos extracts 
Extracts of the unfermented and fermented Rooibos used for the binding assays were 
analysed for flavonoid quantification using HPLC-DAD, as previously done by Beelders et 
al. (2004). The results showed that the unfermented Rooibos extracts had higher levels of 
dihydrochalcones relative to the other flavonoid levels. Within the dihydrochalcone group, 
the concentration of aspalathin was 5.7-fold higher than nothofagin. The unfermented 
Rooibos extract’s flavone content showed that orientin and isoorientin levels were roughly 5-
fold higher than isovitexin and vitexin. The unfermented Rooibos extract’s  flavonol 
concentration showed that quercetin-3-O-rutinoside was roughly 2-fold the level of rutin. The 
fermented  Rooibos  extract’s  flavones,  particularly orientin and isoorientin, were the most 
abundant flavonoids in the extract, although isovitexin and vitexin levels were roughly 5-fold 
lower than isoorientin and orientin. Quercetin-3-O-rutinoside’s level was 5-fold higher than 
rutin  in  the  fermented  extract’s  flavonol  group.  The  fermented  extract’s  dihydrochalcones 
showed that the nothofagin level was 3.5-fold lower than that of aspalathin. 
When comparing the flavonoid levels of both extracts (Table 4.1), the unfermented extract 
demonstrated a higher level of dihydrochalcones. Aspalathin and nothofagin levels were 28-
fold and 19-fold higher respectively in the unfermented extracts than in the fermented 
extracts. The quercetin-3-O-rutinoside level was similar in both extracts, whereas rutin was 4-
fold higher in the unfermented extract than in the fermented extract. The flavones of 
unfermented and fermented Rooibos extracts were similar in level. 
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Table 4.1. Flavonoid compounds (µg) present in the fermented and unfermented Rooibos extracts. 
Flavonoids were extracted from 1 g dried Rooibos plant material. Results are expressed as the mean ± 
SEM. 
4.3.2 Determination of cytochrome P450 enzyme concentration. 
The cytochrome P450 concentrations of the ovine adrenal preparations were determined by 
carbon monoxide induced difference spectra as demonstrated in Figure 4.3, (Omura & Sato 
1964). The sodium dithionate reduced carbon monoxide spectrum is formed from a slow 
reaction, therefore allowing the absorbance at 450 nm to fully develop.  
 
 
 
Flavonoids  Unfermented extract Fermented extract 
 ug ug 
Aspalathin 20556.7 ± 211.9 735.8 ± 10.9 
Nothofagin 3596.8 ± 35.1 186.2 ± 4.5 
Rutin 542.1 ± 5.6 162.8 ±1.9 
Quercetin-3-O-rutinoside 986.2 ± 12.0 1000.8 ±13.8 
Orientin 2196.6 ± 27.8 2158.2 ± 31.2 
Isoorientin  2863 ± 39.4 2524.7 ± 37.3 
Vitexin 424.7 ± 3.3 466.0 ± 3.9 
Isovitexin 524.9 ± 5.1 485.5 ± 4.3 
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A      B 
 
Figure 4.3. Type II carbon monoxide induced difference spectra. Sodium dithionate reduced spectra 
of A) mitochondrial preparation, B) microsomal preparation. Mitochondrial [P450] = 0.7 µM (0.7 
nmol/mg protein) and microsomal [P450] = 1 µM (0.5 nmol/mg protein). 
4.3.4 Substrate binding assays 
The binding assay activity on the ovine adrenal preparations was investigated to determine 
the interference of Rooibos extracts and selected flavonoids (aspalathin, rutin and quercetin) 
in substrate binding to adrenal P450 enzymes. This investigation was based on the unique 
spectral properties of the P450 enzymes. P450 enzymes are heme proteins, since they contain 
a ferric iron. The heme iron’s equilibrium changes between a high and a low spin state in the 
presence of an appropriate substrate in the active site, as mentioned in section 3.4 of Chapter 
3. The high and low spin states of the heme iron have profoundly different spectra, making it 
possible to easily monitor the substrate binding spectroscopically. The change in the spin 
state forms the basis of the type I spectrum. The spectrum has a peak maximum at 390 nm 
and a peak minimum at 420 nm. Any compounds that interfere with the binding of substrate 
to the P450 enzymes reduce the amplitude of the spectrum (viz. a reduced peak maximum 
and increased peak minimum), as shown in Figure 4.2. 
Adrenal mitochondrial preparation contains CYP11A1, CYP11B1 and CYP11B2, whilst the 
microsomal  preparation  contains CYP17A1, CYP21A2  and  3βHSD  steroidogenic enzymes 
(Werck-reichhart & Feyereisen 2000). DOC was chosen as substrate for the mitochondrial 
preparation, as it is the substrate for CYP11B1 and CYP11B2, whilst PROG was chosen as 
the substrate for the microsomal preparation, as it is a substrate for CYP17A1 and CYP21A2. 
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These substrates induce a type I spectrum when they bind to the respective P450 enzymes in 
the presence of varying concentrations of either the Rooibos extracts or the selected 
flavonoids (Table 4.2 and Table 4.3). The concentrations of Rooibos extracts that were used 
for this study ranged from 0.2 mg/ml to 1 mg/ml for unfermented extracts and 0.2 mg/ml to 2 
mg/ml for fermented extracts, while for the flavonoids the concentration ranged from 4 μM to 
53 μM. Substrate binding interference was indicated by the reduction in the amplitude of the 
spectrum (see Figure 4.2). Only the concentrations of the extracts and the flavonoids that 
showed significant inhibitions were recorded. The flavonoid content of the extract 
concentration that affected substrate binding significantly was determined (see Table 4.4). 
The results of the substrate binding studies suggest that the unfermented extract inhibited the 
binding of PROG to the P450 enzymes in the microsomal preparation more than that of the 
fermented Rooibos extract. The unfermented Rooibos extract inhibited the binding more than 
the fermented Rooibos extract when both extracts were used at a concentration of between 
0.2 mg/mL and 0.7 mg/mL (Figure 4.4 A). The fermented Rooibos extract caused a 7.1 % 
inhibition, whilst the unfermented Rooibos extract caused a 21.5 % inhibition. In the 
mitochondrial preparation, in Figure 4.4 B, the results show a similar degree of inhibition, 
where the fermented and unfermented Rooibos extracts inhibited DOC binding by 41 % and 
48 % respectively. When comparing the degree of substrate binding inhibition by the extracts 
at the same concentration for the microsomal and mitochondrial P450 enzymes, it is observed 
that the unfermented Rooibos extract interfered more with substrate binding than the 
fermented Rooibos extract. Also, the results suggest that the fermented extract inhibits 
substrate binding to P450 enzymes in mitochondrial preparations about 5.8-fold more than in 
microsomal preparations, while unfermented Rooibos extract inhibits substrate binding to 
P450 enzymes about 2-fold more in mitochondrial preparations compared to the microsomal 
preparations.  
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A      B 
    
Figure 4.4. Effect of Rooibos extracts on substrate binding to microsomal and mitochondrial P450 
enzymes. Type 1 difference spectra and percentage inhibition of A) PROG (12 μM) binding to ovine 
microsomal P450 enzymes (0.5 nmol/mg protein), B) DOC (13 μM) binding to ovine mitochondrial 
P450 enzymes (0.7 nmol/mg protein) in the presence and absence of unfermented and fermented 
Rooibos extracts. Results were determined by a one way ANOVA, followed by Dunnett's multiple 
comparison test. Only the concentrations that showed significant inhibition values are shown and the 
data is representative of 3 independent measurements. Results are presented as the mean error bars 
present ± SEM, and n = 3. 
At 0.6 mg/mL Rooibos extracts inhibited substrate binding to P450 enzymes in both the 
microsomal and mitochondrial preparations. Overall, Rooibos extracts appeared to interfere 
with substrate binding to P450 enzymes in mitochondrial preparations to a greater extent than 
in microsomal preparations at similar concentrations. 
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Table 4.2. Column statistics illustrating inhibition of PROG (13 μM) and DOC (12 μM) binding P450 enzymes in A) microsomal preparation (0.5 nmol/mg 
protein) and B) mitochondrial preparation (0.7 nmol/mg protein) respectively in the absence and presence of increasing Rooibos extract concentrations (One 
way ANOVA, followed by Dunnett's Multiple Comparison Test, then column statistics (P < 0.001 = ***, P< 0.01= **)). 
Compound 
Microsomal preparation Mitochondrial preparation 
Concentration 
(μM) Abs Mean 
± Std 
(P < 0.001) 
Concentration 
(μM) Abs Mean 
± Std 
(P < 0.001) 
Steroid 
13 0.036 0.036 0.001 12 0.040 0.040 0.020 
Unfermented 
Rooibos 
0.6 0.029 0.029 0.003 ** 0.6 0.018 0.018 0.020 *** 
Fermented 
Rooibos 
0.6 0.032 0.032 0.001 0.5 0.019 0.019 0.020 ** 
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At 13 μM, rutin inhibited PROG binding to P450 enzymes in microsomal preparations by 19 
% percent, whereas a four times greater concentration of quercetin resulted in a similar 
degree of inhibition (see Figure 4.5 A). In mitochondrial preparations a 60.5 % inhibition, at 
a concentration of 18 μM rutin, was observed, while a similar degree of inhibition (65 %) was 
observed when double the concentration of quercetin was used (see Figure 4.5 B). The data 
obtained shows that lower concentrations of both rutin and quercetin resulted in a higher 
degree of inhibition in the mitochondrial preparations than in the microsomal preparations, 
and that substrate binding to P450 enzymes was inhibited more in the mitochondrial 
preparations than in the microsomal preparations. Aspalathin (results not shown because they 
were not statistically significant) did not interfere with substrate binding to the P450 enzymes 
in both the mitochondrial and microsomal preparations. 
A                                                                         B 
      
Figure 4.5. Effect of flavonoids on substrate binding to microsomal and mitochondrial P450 
enzymes. Induced Type 1 difference spectra and percentage inhibition of, A) PROG (12 μM) binding 
to ovine microsomal P450 enzymes (0.5 nmol/mg protein),  B)  DOC  (13  μM)  binding  to  ovine 
mitochondrial P450 enzymes (0.7 nmol/mg protein) in the presence and absence of selected 
flavonoids. Results were determined by a One way ANOVA, followed by Dunnett’s multiple 
comparison test. Only the concentrations that showed significant inhibition values are shown and the 
data is representative of 3 independent measurements. Results are presented as the mean error bars 
present ± SEM, and n = 3. 
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Statistical analysis of substrate binding inhibition in the presence of the selected flavonoids 
showed that, with an increase in concentration of both rutin and quercetin, substrate binding 
to the P450 enzymes in both the mitochondrial and microsomal preparations was inhibited 
(see Table 4.3). The data summarised in Table 4.3 show that the flavonoids interfered with 
substrate binding to the P450 enzymes more in the mitochondrial preparations than in the 
microsomal preparations.  
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Table 4.3. Column statistics illustrating inhibition of PROG (13 μM) and DOC (12 μM) binding P450 enzymes in A) microsomal preparation (0.5 nmol/mg 
protein) and B) mitochondrial preparation (0.7 nmol/mg protein) respectively in the absence and presence of increasing concentrations of the selected 
flavonoid concentrations (One way ANOVA, followed by Dunnett's Multiple Comparison Test then column statistics (P < 0.001 = ***, P< 0.005= *)). 
Compound 
Microsomal preparation Mitochondrial preparation 
Concentration 
(μM) Abs Mean 
± Std 
(P < 0.001) 
Concentration 
(μM) Abs Mean 
± Std 
(P < 0.001) 
Steroid 13 0.036 0.036 0.001 12 0.040 0.040 0.020 
Rutin 6.6 0.021 0.022 0.002 *** 4.4 0.025 0.025 0.004 *** 
20 0.019 0.019 0.002 *** 13 0.024 0.024 0.002 *** 
26 0.016 0.016 0.001 *** 18 0.014 0.014 0.003 *** 
Quercetin 
40 0.026 0.026 0.001 * 18 0.023 0.023 0.002 *** 
53 0.023 0.023 0.001 *** 35 0.014 0.014 0.002 *** 
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The flavonoid levels in Rooibos extracts that significantly inhibited the binding of substrates 
to microsomal and mitochondrial P450 enzymes were determined (see Table 4.4). At a 
concentration of 0.6 mg/mL, unfermented Rooibos extract had higher levels of 
dihydrochalcones compared to flavone and flavonols, where aspalathin was 5-fold higher 
than the nothofagin. The flavones, orientin and isoorientin, were 4-fold higher than vitexin 
and isovitexin. For the flavonols, the quercetin-3-O-rutinoside concentration was 
significantly higher than the rutin concentration. Fermented Rooibos extract had similar 
levels of flavonoids to unfermented Rooibos extract at concentrations of 0.5 mg/ml and 0.6 
mg/ml respectively. The fermented extract had higher levels of flavones, in particular orientin 
and isoorientin, which were double the levels of quercetin-3-O-robinobioside. The level of 
quercetin-3-O-robinobioside was 5.6-fold higher than that of rutin. The nothofagin level was 
fourfold lower than that of aspalathin. The flavones were generally present in higher levels 
than the other flavonoids. 
Table 4.4. Flavonoid compounds (µg) present in the Rooibos extract added to microsomal and 
mitochondrial preparations. Results are expressed as the mean ± SEM. 
 Microsomal preparation Mitochondrial preparation 
Flavonoids (µg) Unfermented 
extract         
(0.6 mg/mL) 
Fermented 
extract       
(0.6 mg/mL) 
Unfermented 
extract      
(0.6 mg/mL) 
Fermented 
extract      
(0.5 mg/mL) 
Aspalathin 78.1 ± 0.8 2.0 ± 0.0 78.1 ± 0.8 2.3 ± 0.0 
Nothofagin 13.7 ± 0.1 0.5 ± 0.0 13.7 ± 0.1 0.6 ± 0.0 
Rutin 2.1 ± 0.0 0.5 ± 0.0 2.1 ± 0.0 0.5 ± 0.0 
Quercetin-3-O-rutinoside 3.7 ± 0.0 2.8 ± 0.0 3.7 ± 0.0 3.2 ± 0.0 
Orientin 8.3 ± 0.1 6.1 ± 0.1 8.3 ± 0.1 6.8 ± 0.1 
Isoorientin  10.9 ± 0.1 7.0 ± 0.1 10.9 ± 0.1 8.0 ± 0.1 
Vitexin 1.6 ± 0.0 1.0 ± 0.0 1.6 ± 0.0 1.5 ± 0.0 
Isovitexin 2.0 ± 0.0 1.4 ± 0.0 2.0 ± 0.0 1.5 ± 0.0 
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4.4. Discussion 
Prior to conducting the substrate binding assays, major flavonoids present in the Rooibos 
extracts were analysed. The analyses showed that the unfermented extract contained higher 
levels of aspalathin, nothofagin and rutin than the fermented extract. Also, these flavonoids 
were present in higher levels in both extracts compared to other flavonoids (see Table 4.5). In 
contrast to the unfermented extract flavonoid levels, the fermented extract contained 
relatively high levels of flavones (isoorientin and orientin) and quercetin-3-O-robinobioside 
compared to the other flavonoids. The flavonoid levels in the unfermented extract were 
similar to the flavonoid content of the unfermented extract as reported by Schloms et al. 
(2013). However, the flavone levels of both extracts were similar. In the flavonol group, rutin 
was 3.3-fold more abundant in the unfermented extract than in the fermented extract. 
Previous studies conducted in our laboratory have shown that the aqueous and methanolic 
extracts of unfermented Rooibos inhibited the binding of PROG to microsomal P450 
enzymes to a greater extent than the aqueous and methanolic extracts of fermented Rooibos. 
Due to this observation, no further investigations were done in the presence of fermented 
Rooibos extracts. Interestingly, however, in the studies conducted by Perold (2009) it was 
shown that the aqueous extracts of unfermented Rooibos inhibited PROG binding to P450 
enzymes in the microsomal preparations more than in the methanolic unfermented extracts 
(Perold 2009). In the current study it was observed that both the methanolic extracts of 
Rooibos interfered with substrate binding to P450 enzymes in the microsomal and 
mitochondrial preparations.  
The investigation has shown that PROG is inhibited from binding to microsomal 
steroidogenic enzymes by unfermented extract to a higher degree than by the fermented 
Rooibos extract at the same concentration (0.6 mg/mL). These results corroborate previous 
findings by Perold (2009) on the effect of methanolic Rooibos extracts on microsomal P450 
enzymes. In this study it was found that methanolic extracts of unfermented Rooibos 
inhibited the binding of PROG to microsomal enzymes to greater extent than the methanolic 
extract of fermented Rooibos (Perold 2009). This could be attributed to the high levels of 
flavonoids found in unfermented extracts, which could have competitively inhibited the 
binding of PROG (see Table 4.5). However, in the mitochondrial preparation, DOC binding 
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was inhibited to the same degree (roughly 60 %) and at a similar concentration of both 
Rooibos extracts (0.5 to 0.6 mg/mL). This could be due to the quercetin-3-O-robinobioside 
and flavone levels being similar in both extracts (see Table 4.4) and having a combined 
inhibitory effect on the substrate binding to the P450 enzymes.  
Since flavonoids have been reported to modulate P450 enzyme activity, in particular 
CYP17A1 and CYP21A2 (Buters 1997; Ohno et al. 2002), flavonoids were used to determine 
the interference with substrate binding in the mitochondrial and microsomal preparations. 
Flavonols (rutin and quercetin) and aspalathin were used for this investigation. The flavonols 
inhibited the substrate binding in both the preparations in a dose-dependent manner (Table 
4.3).  Low  concentrations  of  rutin  (13  μM  and  18  μM)  inhibited  the  microsomal  and 
mitochondrial P450 enzymes more than quercetin, which was used at higher concentrations 
(53 μM and 35 μM). These  findings  suggest  that  rutin  is more  potent  than  quercetin, as it 
results in the inhibition of substrate binding to P450 enzymes at lower concentrations than 
quercetin. It can be speculated that rutin is able to form a stable complex that binds in the 
active site of the P450 enzymes. Moreover, it is assumed that the substrate binding 
interference caused by rutin and quercetin is due to the hydroxyl groups at the 6
th
 position of 
their pyran ring and 4
th
 position on their benzene ring. Ohno et al. (2002) reported this 
assumption to be the cause of the inhibition of the production of cortisol in H295R cells. 
Varying concentrations of aspalathin were found not to inhibit substrate binding (results not 
shown). Aspalathin has been reported by Schloms et al. (2012) to affect P450 enzyme activity 
(mechanism unknown), it is also possible that higher concentrations of aspalathin, such as 
that found in Rooibos, could interfere with substrate binding to P450 enzymes.  
4.5.  Conclusion 
The substrate binding assays carried out showed that unfermented and fermented Rooibos 
and flavones (quercetin and rutin) interfere with substrate binding to adrenal P450 enzymes, 
and that aspalathin does not interfere with substrate binding. Rutin is more potent than 
quercetin; therefore it is possible that the inhibition seen with Rooibos extract could be due 
mainly to the presence of rutin.  
Although the investigations described above show the interference of Rooibos and flavonoids 
with substrates binding to the enzymes, these assays do not reflect their influence on the 
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catalytic activity of the specific P450 enzymes. Consequently, substrate conversion assays 
were conducted to determine the influence of Rooibos and flavonoids on the catalytic 
activities of the enzymes.  
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CHAPTER 5 
The influence of Rooibos (Aspalathus linearis) on adrenal steroidogenesis 
5.1. Introduction 
The endocrine system is responsible for the regulation and maintenance of physiological 
functions. The system comprises various endocrine glands that include the pituitary gland, 
ovaries, testes, thyroid gland and the adrenal gland. The endocrine glands produce hormones 
that are messengers secreted to act on target tissues or organs to regulate physiological 
functions. The adrenal gland is a complex organ involved in the biosynthesis and secretion of 
steroids by specific enzymes, which were as described in Chapter 3. Steroidogenic enzymes 
(P450 enzymes and HSDs) are biological catalysts involved in the biosynthesis of steroids 
(glucocorticoids, mineralocorticoids and androgens). Steroids control many physiological 
processes via endocrine signalling pathways, and contribute to the transcriptional regulation 
of P450 enzymes. As discussed in Chapter 3, the steroids are synthesised from cholesterol 
and are transported via diffusion or the blood stream to elicit their biological activities.  
The regulation of steroidogenesis generally involves the HPA axis and the RAAS, which are 
examples of endocrine feedback loops regulated by circulating steroids. Any changes in 
steroidogenic enzyme activity can alter steroid metabolism and, consequently, the 
concentrations of circulating plasma steroids. The alteration of the circulating steroids can 
lead to an imbalance of water and mineral homeostasis, glucose homeostasis and sexual 
development, thus leading to clinical conditions. Inadequate levels of mineralocorticoids, 
mainly ALDO, and glucocorticoids, mainly cortisol, have been reported to be associated with 
most of the endocrine diseases such as hypertension, diabetes, stress and anxiety.  
The consumption of Rooibos herbal infusions has been reported to aid endocrine related 
illnesses that are linked to abnormal levels of adrenal steroids, as mentioned in Chapter 2, 
section 2.6. Some studies have shown that fermented Rooibos has the ability to inhibit the 
activity of ACE, an important enzyme involved in the RAAS activity, in human volunteers 
(Persson et al. 2010). The effects of Rooibos on human health, including anti-mutagenic, 
anti-fungal and anti-oxidant capacity, have been investigated and validated by various studies 
mentioned in Chapter 2, but its influence on the endocrine system is not widely reported. In a 
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study done by Schloms et al. (2012), they observed a decrease in total steroids produced in 
H295R cells in the presence of methanolic extracts of unfermented Rooibos under stressed or 
stimulated conditions. In the same investigation it was shown that CYP17A1 and CYP21A2, 
expressed in COS-1 cells, were inhibited by 10 µM dihydrochalcones (asphalathin and 
nothofagin) (Schloms et al. 2012). These studies show that unfermented Rooibos have a 
direct effect on the P450 enzymes catalysing steroidogenesis. 
The main objective of this study was to investigate the influence of Rooibos and selected 
flavonoids on the catalytic activity of individual P450 enzymes found in the microsomes and 
mitochondria, charged with the primary function of catalysing adrenal steroid biosynthesis. 
The influence of Rooibos was also investigated in H295R cells, an adrenal cell model, to 
determine the effect on the overall steroidogenesic output. Not only will these investigations 
demonstrate the influence of methanolic extracts of Rooibos and selected flavonoids on P450 
enzyme activity, but also its effect on the flux through the steroidogenesis pathway. These 
studies allow the comparison of the effect of unfermented and fermented Rooibos on 
individual P450 enzymes and the steroidogenic pathway, and the overall steroidogenesis 
assays done in H295R cells. 
Substrate conversion assays were investigated in COS-1 cells in the presence and absence of 
methanolic extracts of Rooibos and selected flavonoids. COS-1 cells, a non-steroidogenic 
monkey kidney cell line, were transfected with expression vectors containing CYP17A1/pCI-
neo and CYP21A2/pCI-neo, while expression vectors containing CYP11B1/pCMV and 
CYP11B2/pCMV were co-transfected with adrenodoxin enzyme (ADX) and the appropriate 
steroids were assayed. CYP17A1 and CYP21A2 enzymes represent the microsomal in vitro 
studies, while CYP11B1 and CYP11B2 enzymes represent the mitochondrial in vitro studies. 
These assays were followed by an investigation into the effects of methanolic extracts of 
Rooibos on steroid hormone production in a human adrenal cell line, H295R.  
5.2. Materials and methods 
5.2.1 Reagents 
Rooibos and selected flavonoids (described in section 4.2.1) were also used in the following 
investigations. PREG, PROG, DOC and deoxycortisol were purchased from Sigma Chemical 
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Co.  (St Louis, MO, USA). Dulbecco’s modified Eagles’s medium  (DMEM),  and forskolin 
were acquired from Sigma Chemical Co. Deuterated cortisol (D4-cortisol) was purchased 
from Cambridge Isotope Laboratories (Andover, MA, USA). Trypan blue, a diazo dye, was 
purchased from InvitrogenTM Life Technologies (Paisley, UK) Penicillin-streptomycin, fetal 
calf serum and trypsin-EDTA were purchased from Gibco-BRL (Gaithersburg, MD, USA). 
Dulbecco’s  modified  Eagles medium/F-12 and gentamicin were purchased from 
Invitrogen/Gibco (Grand Island, NY, USA). Comic calf serum was supplied by HyClone, 
Thermo Scientific (South Logan, UT, USA). Luria broth medium constituents (tryptone, 
yeast extract) were purchased from Difco Laboratories (Detroit, MI, USA). Nucleobond AX 
plasmid preparation kits were purchased from Macherey-Nagel (Duren, Germany).  
COS-1 cells were obtained from the American Type Culture Collection (Manassas, VA, 
USA). Mirus TransITR-LT1 transfection reagent was purchased from Mirus Bio Corporation 
(Madison, WI, USA). H295R cells were a gift from Professor W. E Rainey (Department of 
Obstetrics & Gynecology Biochemistry, and The Cecil H. & Ida Green Centre for 
Reproductive Biology Sciences, Southwestern Medical Centre (Dallas, USA)). The UPLC 
BEH column was purchased from Waters (Milford, MA, USA), and the Kinetex PFP column 
was purchased from Phenomenex (Torrance, CA, USA).  
All other chemicals, of high quality, were purchased from reputable scientific chemical 
supply companies.  
5.2.2 Preparation of methanolic extracts of unfermented and fermented Rooibos. 
Rooibos extracts were prepared by the extraction of plant material using chloroform and 
methanol as described in section 4.2.2 (Chapter 4). The extracted Rooibos was dried and 
resuspended in deionised water (mg/ml). Aliquots were stored at -20 °C until further use. 
Flavonoids (2 mg/ml) and steroids (2 mg/ml) were dissolved in ethanol and stored at 4 °C. 
5.2.3 Preparation of plasmid for transfection. 
Luria broth medium (1 % tryptone, 0.5 % yeast extract, 1 % NaCl) was innoculated with 
transformed E. coli stocks and incubated overnight at 37 °C. Plasmid vectors included pCI-
neo containing Angora CYP17A1 (CYP17A1/pCI-neo), Angora CYP21A2 (CYP21A2/pCI-
neo); pCMV containing human CYP11B1/pCMV and CYP11B2/pCMV; and pCD 
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containing human ADX (pCD-ADX). The cultures were harvested by centrifugation and 
plasmid DNA was isolated using a Nucleobond AX plasmid kit according to the 
manufacturer’s instructions. The plasmids obtained were stored at -20 °C. 
Agarose gel electrophoresis was used to determine the integrity of the isolated plasmids. 
DNA samples of 250 ng, were analysed on an agarose gel, 1 %, in TAE buffer (40 mM Tris, 
20 mM acetic acid and 1 mM EDTA). DNA marker (1 Kb ladder, Promega) and 5 µL 6 X 
Orange DNA loading dye consisting of 10mM Tris- HCl (pH 7.6), 0.15 % orange G, 0.03 % 
xylene cyanol FF, 60 % glycerol and 60 mM EDTA was used. 
5.2.4 Determination of steroid conversion and production in model cell sytems 
The influence of Rooibos on steroid conversion and overall steroidogenesis was assayed in 
COS- 1 cells, a non-steroidogenic cell line, and H295R cells, a human adrenocortical tumour 
cell line respectively.  
5.2.4.1 Culturing and maintenance of COS-1 cells 
COS-1 cells are a cell line derived from kidney tissue of the African green monkey, stably 
transformed with an origin defective mutant of SV40 encoding the wild type T antigen. 
Frozen COS-1 cells (1 ml) were thawed, resuspended and grown in 10 ml sterile culture 
media (DMEM high glucose, containing 0.15 % NaHCO3, 10 % foetal calf serum and 1 % 
penicillin streptomycin) in a 100 mm tissue culture dish at 37 °C, 5 % CO2, 90 %. The media 
was replaced with fresh media on a daily basis until the cells were visibly confluent under the 
microscope. The confluent cells were detached from the plate using trypsin-EDTA (0.25 % 
w/v) and re-suspended in 30 mL culture media.  
Detaching the cells from a 100 mm dish plate involved gently aspirating the media from the 
cells, washing the cells – which had been incubated for 2 min in the presence of 1 mL 
trypsin-EDTA – with 0.5 mL trypsin-EDTA by gentle swirling, which were incubated for 2 
min in the presence of 1mL trypsin-EDTA. Cells were resuspended in 5 mL media to stop 
trypsin-EDTA activity. The suspension was centrifuged at 500 ×g for 5 min and the 
supernatant was discarded. The cells were resuspended in 10 mL of media. At this stage the 
cells can be replated into three sterile 100 mm tissue culture dishes (10 mL/dish) and 
incubated for experimental investigations by further culturing or resuspending in freezing 
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media (culture medium containing 10 % DMSO), and then storing in cryovials at  
-80 °C for 48 hr before storage in liquid nitrogen for future use  
For investigation purposes, confluent cells were replated into 12 well plates (2.5 cm
2
) at 1 × 
10
5
 and incubated for 24 hr. A cell counter (Invitrogen Countess automated cell counter) was 
used to count the cells. Before counting the cells, 10 µL of the resuspended cells were gently 
but thoroughly mixed (to ensure homogeneity) with 10 µL of trypan blue, and 10 µL of this 
was used for counting. Trypan blue is derived from toluidine and not taken up by live cells. 
The method is also referred to as a dye exclusion method, and non-viable cells and viable 
cells are recorded. Viable cells are expressed as follows:  
% viable cells = (1.00 – (Number of blue cells / Number of total cells)) x 100 
The cells were transfected using serum free DMEM, containing  3  μL  transfecting  reagent 
(Mirus) and 1 μg plasmid DNA per 1 ml. For  the co-transfections, 0.5 μg of each plasmid 
vector was used. The transfecting mixture was incubated for 20 min at room temperature, 
after which 50 μL of the mixture was added to the cells. Cells were incubated for 72 hr before 
the addition of substrates and test compounds (extracts and flavonoids). The expression 
vectors listed above were transfected into the cells. The plasmid, pCI-Neo, containing no 
DNA insert, was used as the negative control, and CYP11B1/pCMV was used as the positive 
control in the absence of test compounds. 
5.2.4.2 Determination of steroid conversion assays in COS-1 cells 
The influence of Rooibos and selected flavonoids was investigated on the catalytic activity of 
the P450 enzymes. Substrate conversion was assayed in the absence and presence of Rooibos 
extracts as well as flavonoid compounds. COS-1 cells that were transfected with the 
appropriate plasmids and PROG (1 PM) and PREG (3 PM) were used as substrate for 
CYP17A1, while PROG (1 PM) was used as substrate for CYP21A2. DOC (1 PM) and 
deoxycortisol (1 PM) were used as substrate for CYP11B1, while DOC (1 PM) was used as 
substrate for CYP11B2. CYP11B1 and CYP11B2 were co-transfected with ADX. Substrates 
were added to culture media with or without Rooibos extracts (4.3 mg/mL) or flavonoids (10 
PM).  
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After 72 hr of incubation with transfection media, the media was replaced with culture media 
containing substrates in the presence and absence of extracts and test compounds. The cells 
were incubated and aliquots were removed for steroid extraction at specific time intervals, as 
indicated in the respective figure legends.  
5.2.4.3 Culturing and maintenance of H295R cells 
Although H295R cells express the full complement of human adrenocortical enzymes, the 
cell line is insensitive to ACTH stimulation (Xing et al. 2011). ACTH stimulates 
steroidogenesis in the adrenal glands, as mentioned in section 3.7.1 of Chapter 3. In addition 
to its role in steroidogenesis, ACTH is known to increase the expression of steroidogenesis 
enzymes in the adrenal cortex (Engeland et al. 1997). Forskolin, a diterpene, was used in the 
assays described below since the compound stimulates the adenyl cyclase (cAMP) pathways 
in adrenal cells (Seamon et al. 1981), which mimic the action of ACTH.  
Frozen H295R cells (1 ml) were thawed and re-suspended by sieving them with a sterile cell 
sieve and they were subsequently grown in 10 ml sterile growth media (DMEM/F12, which 
contained 0.15 % NaHCO3/L, 10 % cosmic calf serum, 1 % penicillin streptomycin and 0.05 
% gentamycin) in a 100 mm tissue culture dish at 37 °C, 5 % CO2, 90 %. The media was 
replaced with fresh media after every 24 hr. Detaching confluent cells from the tissue culture 
dish also involved 0.5 mL trypsin-EDTA, as described in section 5.2.4.1. For investigative 
purposes, confluent cells were replated into 12-well CellBind™ (Corning) dishes at 4 × 105 
cells/ml/well after centrifugation through a cell strainer (40 µm) to remove cell aggregates. 
Cells were incubated for 48 hr in growth medium, which were then followed by a 12 h 
incubation process with growth medium containing 0.1 % cosmic calf serum, after which 
treatment of the cells commenced. 
5.2.4.4 Determination of steroid production in H295R cells 
The influence of Rooibos (1 mg/mL) extracts on steroid hormone production in H295R was 
assayed in the absence (basal conditions) and presence of forskolin (stimulated conditions). 
Basal conditions were assayed in the presence or absence of Rooibos extracts (final 
concentration of 1 mg/mL) for 48 hr. Stimulated conditions were assayed for 48 hr in the 
presence and absence of Rooibos extracts (final concentration, 10 μM), with the addition of 
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forskolin (final concentration of 10 μM). Aliquots of 500 μl were removed from each well, 
D4-cortisol (15 ng) was added as internal standard, after which the steroids were extracted 
and analysed as described in section 5.2.6.  
5.2.5 Cell viability assay in the presence of Rooibos extracts 
The effect of fermented and unfermented Rooibos extracts on cell viability was assayed to 
determine whether experimental concentrations affected the cells adversely. Confluent cells 
were replated into 12 well plates at 1 × 10
5
 and incubated for 12 hr, after which the cells were 
incubated for 12 hr with culture medium containing 4.3 mg/mL Rooibos extract. Viability 
was assayed using the trypan blue dye exclusion method. Cells were harvested using 0.5 mL 
of trypsin. The cells were centrifuged at 500 ×g for 5 min at room temperature. Trypsin was 
aspirated off and the cells were resuspended in 0.5 mL of phosphate buffered saline. Viable 
cells were determined using trypan blue, as described in section 5.2.4.1. 
Protein determination was carried out on the remaining cell suspension, as described in 
section 4.2.5 of Chapter 4, using the Pierce BCA Protein Assay Kit (Rockford, IL, USA) 
according to the instructions of the manufacturer. The cells were sonicated and a dilution 
series was prepared (10 X, 5 X and 2 X) for the determination. 
Rooibos has been shown to have no effect on the viability of H295R cells (Schloms et al. 
2012) and viability therefore was not assessed in this study. 
5.2.6  Extraction and determination of substrate and product steroids 
Steroids were extracted and quantified according to the method reported by Schloms et al. 
(2012). The media  (500  μL)  removed from the culture medium (see section 5.2.4) was 
transferred to centrifuge tubes containing 5 mL of dichloromethane, shaken for 20 min and 
centrifuged at 1200 ×g for 5 min. The media was removed and the dichloromethane was dried 
off under nitrogen gas  at  40  °C. Dried  steroids were  resuspended  in 150 μL methanol  and 
transferred to glass vials for analysis by ultra-performance liquid chromatography tandem 
mass-spectrometry (UPLC-MS/MS). Steroids were separated using a Waters UPLC BEH and 
a Kinetix PFP column using solvent A (1 % formic acid) and solvent B 
(methanol:acetonitrile:isopropanol, 49 %:49 %:1 %). The solvents improve the 
chromatographic peak shape and provide a source of protons. Steroids were separated using a 
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linear gradient from 85 % A to 80 % B in 3.5 min, followed by a linear gradient from 80 % B 
to 100 % B in 0.1 min and an isocratic elution with solvent B for 1 min. Metabolites in a 5 ul 
sample volume were separated at a flow rate of 0.4 ml/min in 5 min.  
The percentage inhibition of substrate conversion was calculated as follows: 
% Inhibition = 100 – ((X/S) x 100)                     (Eq. 5.1) 
where X = % conversion of steroid in the presence of inhibitor, and S = % of steroid in the 
absence of inhibitor. 
5.2.7 Statistical analysis 
Statistical analyses were performed using GraphPad Prism Version 5.0 for Windows 
(GraphPad Software, San Diego, California, USA) and calculated by a one-way ANOVA. All 
experiments were carried out in triplicate and the results are shown as means ± SEM. Values 
of P < 0.05 were considered statistically significant. Statistics are indicated in the respective 
figure legends. 
5.3. Results 
5.3.1 Analyses of Rooibos extracts 
Extracts of unfermented and fermented Rooibos were analysed to determine the levels of the 
major flavonoid compounds. The data shown in Table 5.1 depicts the flavonoids (ug) 
extracted from one gram of Rooibos plant material. The levels of both dihydrochalcones were 
higher in the unfermented Rooibos than in the fermented Rooibos (aspalathin 32-fold and 
nothofagin 22.3-fold), while the aspalathin levels in unfermented Rooibos were 6.1-fold 
higher than nothofagin. Although the flavone levels were similar in the fermented and 
unfermented Rooibos, orientin and isoorientin were ± 6-fold higher than isovitexin and 
vitexin. Analysis of the flavonol compounds showed that, while quercetin-3-O-rutinoside 
appeared to be a more stable compound, rutin was 6-fold lower in the fermented extract. 
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Table 5.1. Flavonoid compounds (µg) present in the fermented and unfermented Rooibos extracts. 
Flavonoids were extracted from 1 g dried Rooibos plant material. Results are expressed as the mean ± 
SEM. 
Flavonoids Unfermented extract
 
Fermented extract
 
 µg µg 
Aspalathin 16838.7 ± 58.8 525.9 ± 8.3 
Nothofagin 2755.5 ± 21.7 123.3 ± 2.7 
Rutin 466.2 ± 0.7 125.0 ± 2.4 
Quercetin-3-O-rutinoside 835.9 ± 2.4 749.8 ± 11.1 
Orientin 1717.8 ± 7.0 1602.6 ± 25.4 
Isoorientin  2129.1 ± 4.7 1848.7 ± 28.7 
Vitexin 322.8 ± 1.7 358.2 ± 4.4 
Isovitexin 368.1 ± 1.9 363.5 ± 6.2 
The levels of flavonoid compounds present in the unfermented and fermented Rooibos 
extracts used in the experimental assays in COS-1 and H295R cells were analysed and are 
shown in Table 5.2. The data clearly shows that extracts of unfermented Rooibos 
administered to the cells contained significantly higher levels of dihydrochalcones than 
flavones and flavanols. Cells assayed in the presence of fermented extracts were exposed to 
higher levels of isoorientin, orientin and quercetin-3-O-rutinoside. Lower concentrations 
were used in the H295R overall steroidogenesis assays because the enzyme concentration is 
not known. 
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Table 5.2. Flavonoid compounds (µg) present in the Rooibos extract administered to COS-1 cells and 
H295R cells. Results are expressed as the mean ± SEM. 
Flavonoids µg administered to cells 
Flavonoids Unfermented extracts Fermented extracts 
 H295R cells
 
COS-1 cells 
 
H295R cells
 
COS-1 cells 
Aspalathin 458.3  ± 1.6 106.6 ± 0.4 3.3 ± 0.1 14.3  ± 0.2 
Nothofagin 75.0  ± 0.6 17.4 ± 0.1 0.8 ± 0.0 3.4  ± 0.1 
Rutin 12.7  ± 0.0 3.0 ± 0.0 0.8 ± 0.0 3.4  ± 0.1 
Quercetin-3-O-rutinoside 22.7  ± 0.1 5.3 ± 0.0 4.7 ± 0.1 20.4  ± 0.3 
Orientin 46.8  ± 0.2 10.9 ± 0.0 10.1 ± 0.2 43.6  ± 0.7 
Isoorientin  57.9  ± 0.1 13.5 ± 0.0 11.7 ± 0.2 50.3  ± 0.8 
Vitexin 8.8  ± 0.0 2.0 ± 0.0 2.3 ± 0.0 9.7  ± 0.1 
Isovitexin 10.0  ± 0.1 2.3 ± 0.0 2.3 ± 0.0 9.9  ± 0.2 
The COS-1 cells were exposed to 4.3mg Rooibos extract/mL and H295R cells to 1mg Rooibos extract/mL. 
5.3.2. Analyses of plasmid DNA 
Plasmid DNA constructs encoding P450 enzymes were purified by alkaline lysis followed by 
anion exchange chromatography, and analysed spectrophotometrically using an ND-100 
Spectrophotometer (NanoDrop; Thermo Scientific, USA). Optical densities were recorded at 
260 nm and 280 nm and the purity of the isolated plasmids was determined (Table 5.3).  
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Table 5.3. Spectrophotometric results of harvested plasmid constructs. 
Plasmid pCI-neo pCD-ADX CYP11B1/pCMV CYP11B2/pCMV CYP17A1/pCI-neo CYP21A2/pCI-neo 
OD260:280 1.79 1.80 1.82 1.84 1.87 1.85 
Total yield (Pg) 270 520 1530 1390 830 1220 
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Although the ratios indicated the expected degree of purity (1.8), genomic contamination may 
affect downstream experiments. A further analysis was carried out using agarose gel 
electrophoresis, which also enabled the determination of DNA integrity. Analyses of the 
bands on the agarose gel (see Figure 5.1) showed that CYP17A1/pCI-neo and pCD-ADX 
CYP11B2/pCMV electrophoresed as two fragments. The lower, darker fragments represent 
the supercoiled plasmid DNA, as these migrated faster, whilst the lighter DNA fragments 
represent the nicked plasmid vectors, which migrated slower. CYP21A2/pCI-neo and 
CYP11B1/pCMV were detected as supercoiled DNA fragments only. 
Lane      1 2      3      4       5      6       7    Kilobases 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1. Agarose gel analysis of purified plasmid DNA. Lane 1: empty; Lane 2: CYP21/pCI-neo; 
lane 3: CYP17/pCI-neo; Lane 4: pCD-ADX; Lane 5: CYP11B2/pCMV; Lane 6; CYP11B2/pCMV 
Lane 7; molecular marker 1 kDa marker. DNA, 250 ng/well, was electrophoresed on a 1 % agarose 
gel, at a constant voltage of 70 V, and stained with ethidium bromide (1 ug/mL) and visualised on an 
ultraviolet light box 
5.3.3 Cell viability 
Prior to conducting enzymatic assays in the COS-1 cells, the cells were exposed to Rooibos 
extracts at the highest experimental concentrations (4.3 mg/mL) to determine the effect on 
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cell viability. The results indicated that, at this concentration, neither unfermented nor 
fermented Rooibos was toxic to the cells after a 12 hr incubation period. A standard protein 
determination was also carried out to determine whether cell growth was influenced and 
whether cell viability could be correlated to protein levels. There was no significant 
difference in cell viability and protein concentration (P > 0.05) when compared to the control 
cells, which were incubated without the addition of Rooibos extracts (Figure 5.2). The data 
show that Rooibos extracts did not affect protein content. Although a slight increase in cell 
viability and protein levels was observed, these were not statistically significant. As the data 
obtained reflected a similar trend to that obtained in previous studies, it was concluded that 
the viability of COS-1 cells was not affected by the concentrations used in experimental 
protocols. 
 
Figure 5.2. Cell viability and protein analyses of COS-1 cells incubated in the presence of 4.3 mg/mL 
unfermented and fermented Rooibos extracts. Results are a representative of one experiment with 
triplicate data points and were analysed using a one way ANOVA, followed by Dunnett's Multiple 
Comparison Test. Error bars represent ± SEM values. 
5.3.4 Analyses of steroid conversion assays in COS-1 cells  
The  influence  of  Rooibos  extracts  (4.3  mg/mL)  and  selected  flavonoids  (10  μM)  on  the 
catalytic activities of the homologously expressed microsomal enzymes, CYP17A1 and 
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CYP21A2, and mitochondrial enzymes, CYP11B1 and CYP11B2, was investigated in COS-1 
cells.  
The conversion of PREG and PROG, both substrates of CYP17A1, was assayed in the 
presence and absence (control) of Rooibos and selected flavonoids after 8 hr (Figure 5.3). 
The results showed 13 % and 18 % inhibition of PREG conversion in the presence of 
unfermented and fermented Rooibos extracts respectively (Figure 5.3 A). PROG conversion 
by CYP17A1 was inhibited by 34 % and 50 % in the presence of unfermented and fermented 
Rooibos extracts respectively (Figure 5.3 B). Three flavonoid compounds were subsequently 
assayed, namely quercetin, rutin and aspalathin, with only the latter two influencing the 
substrate conversion by CYP17A1. PREG conversion by CYP17A1 was inhibited by 14 % 
and 36 % in the presence of rutin and aspalathin respectively (see Figure 5.3C). Rutin did not 
significantly affect the conversion of PROG; while it would appear that aspalathin stimulated 
the conversion of PROG (see Figure 5.3D). PREG was assayed at 3 μM instead of 1 μM, as 
previous studies conducted in our laboratory (results not published) showed that PREG 
assays at 3 μM give better product analyses than 1 μM PREG.  
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A      B 
   
C      D 
    
Figure 5.3. Influence of Rooibos extracts and selected flavonoids on PREG (3 μM) and PROG (1 
μM) conversion in COS-1 cells by baboon CYP17A1. Percentage substrate and product with A) 
PREG and B) PROG in the presence of unfermented and fermented Rooibos extracts (4.3 mg/mL); C) 
PREG and D) PROG in the presence of quercetin (10 μM), rutin (10 μM) and aspalathin (10 μM), 
assayed after 8 hr. Individual steroids were compared by a Two-way ANOVA followed by 
Bonferroni’s posttest. Results are presented as the mean error bars and represent ± SEM (P < 0.05 = *, 
P  < 0.01 = **, P < 0.001 = ***; n = 3). 
The conversion of PROG by CYP21A2 was assayed after 8 hr (Figure 5.4). The results 
showed significant inhibition of PROG conversion, which was 30 % and 90 % in the 
presence of unfermented and fermented Rooibos extracts respectively (Figure 5.4 A). 
Interestingly, of the flavonoids tested, quercetin exhibited the highest inhibition of PROG 
conversion, at 87 %, while 17 % and 24 % was obtained in the presence of rutin and 
aspalathin respectively. 
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A       B 
       
Figure 5.4. Influence of Rooibos extracts and selected flavonoids on PROG (1 μM) conversion in 
COS-1 cells by human CYP21A2. Percentage substrate and product with A) PROG in the presence of 
unfermented and fermented Rooibos extracts (4.3 mg/mL) and B) PROG in the presence of quercetin 
(10 μM), rutin (10 μM) and aspalathin (10 μM) assayed after 12 hr. Individual steroids were 
compared by a Two-way ANOVA  followed  by Bonferroni’s  posttest. Results are presented as the 
mean error bars and represent ± SEM (P < 0.05 = *, P < 0.001= ***; n = 3). 
Both DOC and deoxycortisol are natural substrates for CYP11B1 and the influence of 
Rooibos on this enzyme was thus determined. In the presence of unfermented and fermented 
Rooibos, the inhibition of DOC conversion by the former was only 8 % with a greater degree 
of inhibition, 41 %, being obtained with the latter (Figure 5.5 A) after 8 hr. The inhibition of 
deoxycortisol conversion was greater than that of DOC, by 32 % by unfermented extract and 
64 % by fermented extract after 6 hr (see Figure 5.5 B). While DOC conversion was not 
inhibited in the presence of any of the selected flavonoids (Figure 5.5 C), the inhibition of 
deoxycortisol conversion was also low with 10 % inhibition detected in the presence of rutin 
and aspalathin (see Figure 5.5 D). 
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A      B 
     
C      D 
           
Figure 5.5. Influence of Rooibos extracts and selected flavonoids on DOC and deoxycortisol 
conversion in COS-1 cells by human CYP11B1 and ADX. Percentage substrate and product with A) 
DOC (1 μM) and B) deoxycortisol (1 μM) in the presence of unfermented and fermented Rooibos 
extracts (4.3 mg/mL); C) DOC (1 μM) and D) deoxycortisol (1 μM) in the presence of quercetin (10 
μM), rutin (10 μM) and aspalathin (10 μM). DOC and deoxycortisol conversion was assayed after 8 
and 6 hr, respectively. Individual steroids were compared by a Two-way ANOVA followed by the 
Bonferroni’s posttest. Results are presented as the mean error bars and represent ± SEM (P < 0.01 = 
**; n = 3). 
DOC conversion by CYP11B2 was assayed after 12 hr, as DOC is also a substrate for 
CYP11B2 in the mineralocorticoid pathway of adrenal steroidogeneis. CYP11B2 was 
inhibited at 26 % and 41 % in the presence of unfermented and fermented Rooibos extracts 
respectively (Figure 5.6 A). DOC conversion was inhibited significantly at 17 % in the 
presence of rutin while no inhibition was detected with quercetin or aspalathin (Figure 5.6 B).  
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A           B  
     
Figure 5.6. Influence of Rooibos extracts and selected flavonoids on DOC conversion in COS-1 cells 
by human CYP11B2 and ADX. Percentage substrate and product with  A)  DOC  (1  μM)  in  the 
presence of unfermented and fermented extracts and B) DOC (1 μM) in the presence of quercetin (10 
μM), rutin (10 μM) and aspalathin (10 μM), assayed after 12 hr. Individual steroids were compared by 
a Two-way ANOVA followed by the Bonferroni’s posttest. Results are presented as the mean error 
bars and represent ±SEM (P < 0.001= ***; n = 3).  
Empty plasmids (pCI-neo) that do not contain DNA insert were used as the negative control 
in the assays above. Cells were transfected with the vector, after which the same experimental 
protocol was followed. Steroid substrates were added and the media was analysed for 
products at appropriate times. Figure 5.7 shows the data collected for the control parameters 
in which the conversion of DOC (1 μM)  by  CYP11B1, expressed in COS-1 cells, was 
assayed as a positive control. The results, shown in Figure 5.7, indicate that the predominant 
hydroxylase activity of CYP11B1 in the positive control assay led to the production of CORT 
(steroid metabolite product), with negligible DOC being detected. No product was detected in 
the negative control assay, indicating that the activity detected was due to the expressed 
enzyme in the positive control.  
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Figure 5.7. Positive and negative control assays in COS-1 cells transfected with CYP11B1/pCMV 
and pCI-neo plasmids respectively. Cells were incubated for 6 hr in  the presence of DOC  (1 μM). 
Results are of triplicate experiments with triplicate data points. Error bars represent ± SEM and n = 3. 
5.3.5  Analyses of basal and forskolin stimulated steroid hormone production in 
H295R cells in the presence of Rooibos extracts.  
The influence of unfermented and fermented Rooibos extracts on steroid levels was 
investigated in H295R cells that express all the steroidogenic enzymes. These cells produce 
the mineralocorticoids, glucocorticoids and adrenal androgens, thus making them an excellent 
model for studying steroidogenesis in the presence of Rooibos extracts under both basal and 
forskolin stimulated conditions.  
The steroid hormone output under basal and stimulated conditions in the presence of Rooibos 
extracts, 1 mg/mL, was assayed after 48 hr. Under basal and forskolin stimulated conditions, 
unfermented Rooibos extract did not decrease the total steroid output significantly. In 
contrast, the fermented extract decreased the total steroid output under both basal and 
forskolin stimulated conditions by Two- and 3-fold respectively (Table 5.4). Under basal 
conditions, extracts of unfermented Rooibos had no significant influence on steroid 
metabolite levels other than testosterone. On the other hand, fermented Rooibos extracts 
increased PREG levels significantly, while significantly reducing basal steroid levels of 
CORT, 16OH-PROG, deoxycortisol, cortisol, testosterone and A4. The inhibitory effect of 
unfermented and fermented Rooibos extracts was more pronounced under stimulated 
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conditions, with both deoxycortisol and A4 levels being significantly decreased in the 
presence of Rooibos extracts. The decrease in all steroid metabolite levels was most 
significant in the presence of fermented Rooibos extract, resulting in an increase in PREG 
and PROG levels due to downstream inhibition of P450 enzymes. 
Table 5.4. Steroid metabolites produced by H295R cells under basal and forskolin (10 μM) stimulated 
conditions in the presence of unfermented and fermented Rooibos extracts (1 mg/mL) after 48 hr.  
Steroid 
Basal + Unfermented Extract + Fermented Extract 
nM ±SEM nM ±SEM Fold change nM ±SEM Fold change 
PREG 99.4 ±13.7 92.5 ± 23.9   283.6 ± 64.4 2.9*↑ 
PROG 14.6 ± 1.3 17.2 ± 4.7   22.2 ± 6.3  
DOC 199.9 ± 27.9 335.0 ± 61.5   164.4 ± 29.6  
CORT 264.9 ± 10.4 364.3 ± 49.2   130.8 ± 30.9  2*↓ 
ALDO 2.7 ± 0.4 6.2 ± 3.0   4.2 ± 0.9  
17OH-PROG 44.3 ± 5.2 44.9 ± 7.8   48.4 ± 12.1  
16OH-PROG 92.3 ± 6.8 65.6 ± 10.3   27.0 ± 11.0 3.4**↓ 
Deoxycortisol 2686.5 ± 75.7 2102.1± 95.4   1245.2±  24.0 2.2**↓ 
Cortisol 1502.2±173.9 1252.9 ± 63.8   698.6 ± 132.2 2.2*↓ 
DHEA 104.8 ± 22.7 77.9 ± 19.3   77.6 ± 41.2  
DHEA-S 17.0 ± 3.8 6.6 ± 3.3   10.6 ± 0.5  
A4 698.6 ± 60.1 514.8 ± 68.9   237.3 ± 30.6 2.9***↓ 
11ΒOH-A4 173.8 ± 13.5 153.1 ± 25.9   110.5 ± 19.6  
Testosterone 32.7 ± 2.9 20.3 ± 3.9  1.6*↓ 5.6 ± 1.6 5.8***↓ 
Total Steroids(nM) 6831.645 5814.867 3497.816 
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Table 5.4. Continuation 
Steroid  
Forskolin  + Unfermented Extract + Fermented Extract 
nM ±SEM nM ±SEM Fold change nM ±SEM Fold change 
PREG 690.4 ± 65.6 803.2 ±166.1   696.9 ±96.7  
PROG 31.1 ± 2.3 35.7 ± 4.0   38.5 ± 7.9  
DOC 838.1 ± 136.3 562.9 ± 88.8   260.0 ± 27.8 3.2**↓ 
CORT 2515.6± 311.9 2286.2± 313.9   497.3 ± 55.8 5***↓ 
ALDO 27.6 ± 5.0 35.0 ± 4.6   11.1 ± 0.8  
17OH-PROG 64.5 ± 10.9 30.8 ± 2.8   58.8 ± 16.4  
16OH-PROG 73.7 ± 6.7 43.6 ± 12.3   19.1 ± 5.4 3.9**↓ 
Deoxycortisol 2586.9 ± 
496.6 
1179.8 ±183.0  2.2*↓ 785.0 ± 62.8 3.3**↓ 
Cortisol 4038.7 ±503.6 3619.0 ± 
605.1 
  1124.7±93.3 3.6**↓ 
DHEA 339.6 ± 62.7 287.3 ± 23.7   260.3 ± 35.9  
DHEA-S 9.1 ± 0.0 3.3 ± 3.3   9.9 ± 0.8  
A4 642.1 ± 95.6 322.4 ± 58.6  2* ↓ 145.4 ± 12.0 4.4***↓ 
11βOH-A4 207.4 ±10.4 199.6 ± 44.3   82.5 ± 7.4 2.5* ↓ 
Testosterone 15.5 ± 3.0 5.1 ± 0.8   1.2 ± 0.6  
Total Steroids(nM) 14444.3 11658.29 4658.784 
Fold changes, indicating only significant ↑ (increase) or ↓ (decrease) in steroid levels, were calculated from the 
changes in absolute values of the individual steroids compared to basal and forskolin stimulated values. 
 P values were calculated using One-way ANOVA followed by Dunnett’s multiple comparison test.  (*p < 0.05, 
**p < 0.01, ***p < 0.001).Data is representative of a single experiment performed in triplicate. Steroids, 
(nmol/L) are expressed as the mean ± SEM (n = 3).  
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5.4. Discussion 
The major polyphenols present in extracts of unfermented and fermented Rooibos were 
analysed in the current study. COS-1 cells were then incubated with these extracts to 
investigate their effects on P450 enzymes. Since COS-1 cells do not express P450 enzymes, 
expression vectors for specific P450 enzymes were transfected into these cells respectively. 
The influence of the extracts was also investigated on steroidogenesis in H295R cells that 
express all steroidogenic enzymes. It is widely reported that unfermented Rooibos contains 
higher levels of polyphenolic compounds than fermented Rooibos. It has also been shown 
that unfermented Rooibos contains significantly higher levels of dihydrochalcones, aspalathin 
and nothofagin than fermented Rooibos (Bramati et al. 2002; Joubert et al. 2008; Beelders et 
al. 2012). Analyses of the extracts used in this study also showed that the unfermented 
extracts contained higher levels of the polyphenolic compounds that were quantitated, with 
aspalathin and nothofagin being present at higher levels in the unfermented extracts (Table 
5.2). Among the other major flavonoids analysed, all of which were found to be at similar 
levels in both the unfermented and fermented extracts, rutin was detected at significantly 
higher levels (3-fold) in the unfermented extracts. High levels of dihydrochalcones and rutin 
were also noted in the study conducted by Beelders et al. (2012). Remarkably, in both the 
unfermented and fermented extracts, isoorientin and orientin were present at higher levels 
than isovitexin and vitexin (± 5-fold). Similar findings were reported, where the mentioned 
flavones were detected at similar levels in unfermented and fermented extracts, with vitexin 
and isovitexin levels being lower than orientin and isoorientin (Beelders et al. 2012). The data 
in the current study correlate with polyphenol levels reported by Schloms et al. (2013), albeit 
at marginally lower levels. To date, 47 polyphenolic compounds have been identified in 
Rooibos (Joubert et al. 2008; Beelders et al. 2012), and not all phenolic compounds were 
analysed in the current study.  
The influence of Rooibos extracts and selected flavonoids on the substrate conversion by 
heterologously expressed P450 enzymes was subsequently assayed. Included in the study was 
aspalathin, being the most abundant polyphenol compound in unfermented Rooibos. Rutin 
and quercetin represent flavonol compounds, with rutin, a diglycosylated derivative of the 
aglycone quercetin, also present at higher levels in unfermented Rooibos. Quercetin is only 
present in trace amounts in unfermented and fermented Rooibos and cannot be quantitated 
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accurately (Beelders et al. 2012). The flavonoid compound was included as it might be a 
representative of the absorbed form of rutin, having passed through the gut microbiome (Del 
Rio et al. 2013).  
Previous studies conducted in our laboratory by Perold (2009) on the influence of Rooibos on 
steroid conversion in adrenal microsomes showed that unfermented and fermented Rooibos 
had similar inhibitory effects on the catalytic activity of CYP17A1 and CYP21A2. Both 
PREG and PROG conversion in adrenal microsomal preparations was significantly inhibited, 
at 90 % and 80 % respectively. Subsequent assays carried out in COS-1 cells transiently 
expressing these enzymes showed the inhibition of CYP21A2 to be higher than that of 
CYP17A1. In addition, while the inhibition of PROG conversion by CYP21A2 by 
unfermented and fermented Rooibos was similar (70 %), inhibition of CYP17A1 by 
unfermented extracts was ± 1.7-fold higher than that observed with fermented extracts 
(Perold 2009). In this study, both CYP17A1 substrates, namely PREG and PROG, were 
assayed. While the inhibition of PREG conversion by the two extracts was similar, the 
inhibition of PROG conversion was greater (1.5-fold) for fermented extract than unfermented 
extract. In addition, inhibition of PROG conversion by CYP21A2 in the presence of 
fermented extracts was also higher than the inhibition exhibited by the unfermented extract. 
Inhibition of the mitochondrial enzymes was also shown to be higher in the presence of 
fermented extracts, at 5-fold and 2-fold, in the case of CYP11B1 conversion of DOC and 
deoxycortisol respectively, and 2-fold in the case of CYP11B2 conversion of DOC. In a 
recent publication, Schloms et al. (2014) reported a 50 % and 55 % inhibition of PREG and 
PROG conversion by CYP17A1 and CYP21A2 respectively in the presence of unfermented 
extract, which is markedly higher than that found in the present study, namely 13 % and 30 % 
respectively. In the present study, PREG was assayed at a 3-fold higher concentration to 
facilitate product analyses, which also accounts for the high level of substrate remaining in 
the control assay after 8 hr. However, the inhibition of the conversion of PROG by CYP17A1 
was 34 %, which was  assayed  at  1  μM  in  the  presence  of  unfermented extracts. Since the 
assays conducted in COS-1 cells in the present study, as well as in the previous studies, were 
carried out using the same concentration of Rooibos extracts (dried extracted plant 
material/ml), the differences observed in the inhibitory effects may be due to differences in 
Rooibos plant material that resulted from natural variation, or the processing and storage of 
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experimental samples. Taken together it can nevertheless be concluded that both unfermented 
and fermented Rooibos influence the microsomal and mitochondrial P450 enzymes. 
Aspalathin, which is a representative of the major polyphenolic compound in Rooibos, was 
subsequently assayed, as were rutin and quercetin. At 10 μM, aspalathin generally inhibited 
PREG and PROG conversion by CYP17A1 and CYP21A2 respectively, while exhibiting no 
inhibitory effect on CYP11B1 and CYP11B2. The inhibition of PREG conversion (36 %) 
was comparable to the inhibition (35 %) previously reported by Schloms et al. (2014). 
Interestingly, the data shows that aspalathin appears to stimulate the conversion of PROG to 
17OH-PROG by CYP17A1. In the previous study, which showed inhibition in this case, 
PROG conversion was assayed for only 4 hr. It is also important to note that the unfermented 
and fermented extracts used in the assays contained different levels of aspalathin, at 1 mM 
and 31 μM, and rutin, at 20 μM and 5 μM. Rutin was previously shown to inhibit both the 
activity of CYP17A1 towards PREG, as well as the conversion of deoxycortisol by 
CYP11B1. Data indicated that the inhibition of CYP11B1 was substrate specific, as greater 
inhibition was detected with deoxycortisol than with DOC as substrate (Schloms & Swart 
2014). In the present study, however, rutin was shown to exhibit a greater inhibitory effect 
towards CYP11B2, which was not investigated previously. Previous studies conducted in our 
laboratory showed rutin also inhibited the conversion of PROG by CYP21A2 at 3 μM and 10 
μM  (Perold 2009). It would seem from the data obtained in the present study that the 
flavonoids assayed had the greatest effect on CYP21A2 activity. The conversion of PROG 
was inhibited significantly (17 %); however, at the same concentration, the inhibition by 
quercetin was 87 %. It thus is possible that the rutinosyl moiety at C3 of rutin interferes with 
the flavonol binding to CYP21A2. The present study shows that the inhibition of the catalytic 
activity of the P450  enzymes  obtained with  the  individual  flavonoid  compounds  at  10 μM 
cannot be linked directly with the inhibition obtained by the unfermented and fermented 
rooibos extracts. These results indicate that there are other factors to consider when assaying 
the inhibitory activity of Rooibos extracts. The unfermented and fermented extracts contained 
higher levels of aspalathin, at 100-fold and 3-fold respectively, than the individual flavonoid, 
which was assayed at 10 μM. Rutin was present at 2-fold higher levels in the unfermented 
extracts and at lower levels in the fermented extracts. It is possible that other compounds 
present in the extract may interfere with the enzyme/substrate/compound interaction, or that 
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compounds may bind to each other when present in high concentrations and thus not be able 
to interfere with the formation of the enzyme/substrate complex. 
Since Rooibos extracts influenced the steroidogenic P450 enzymes catalysing the 
biosynthesis of adrenal steroids in the COS-1 cells, the effect of the Rooibos extracts on 
steroid production was investigated in the H295R cells. As mentioned earlier in section 5.2, 
H295R cells retain the ability to secrete steroid hormones after stimulation with the ACTH, 
either Ang II or forskolin. Forskolin was used in this study, as H295R cells have a low 
response to ACTH due to the low expression of ACTH receptors (Mountjoy et al. 1994). The 
diterpene, forskolin, is an agonist of the protein kinase A pathway, thus mimicking ACTH 
effects (Rainey et al. 1994). Forskolin directly stimulates adenyl cyclase and has been used 
extensively to increase the cAMP involved in steroid biosynthesis (Seamon et al. 1981). 
Previous studies on the role of transport systems in cortisol release in H295R cells showed 
that forskolin increased mRNA expression for important enzymes in steroidogenesis. The 
mRNA  expression  of  CYP11A1,  3βHSD,  CYP17A1,  CYP21A2 and CYP11B1 increased 
significantly (Asif 2004). Another study, conducted by Holland et al. (1993) on the influence 
of forskolin on H295R cells, showed an increase in steroid output after stimulation with 10 
μM  forskolin, and an increase of the mRNA of CYP11B2 in H295R cells (Holland et al. 
1993). 
Data analyses showed that forskolin increased the total steroid output by 2-fold with 
increased steroid metabolites in the mineralocorticoid, glucocorticoid and androgen 
pathways. The data obtained showed that, although the steroid flux through the androgen 
pathway increased, the mineralocorticoid and glucocorticoid pathways showed a greater 
increase in metabolites, with the end products, ALDO and cortisol, increasing 10-fold and 
2.7-fold respectively in the presence of forskolin. In a study conducted by Winther et al. 
(2013), they showed that there was a 2-fold increase in cortisol output when H295R cells 
were stimulated with forskolin, which corroborates the current study’s data showing cortisol 
output being increased by 2.7-fold in the presence of forskolin.  
Under both basal and forskolin stimulated conditions, fermented Rooibos decreased total 
steroid output ± 2- and ± 3-fold. There also was a significant increase in PREG levels under 
basal conditions in the presence of fermented Rooibos extract, possibly due to the inhibition 
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of CYP17A1 or 3βHSD. A4 levels were reduced in the presence of both Rooibos extracts, 
suggesting the inhibition of 3βHSD under basal and forskolin-stimulated conditions. Studies 
by Ohno et al. (2002) on the inhibitory effects of phytoestrogen flavonoids in cAMP 
stimulated H295R reported a significant decrease of 3βHSD activity in  the presence of  low 
concentrations of flavonoids (IC50= 0.5- 2.7 μM). The steroidogenic enzyme 3βHSD is a key 
enzyme that plays a central role at the branch point in steroid biosynthesis in adrenals. 
Moreover, the studies showed competitive inhibition of PROG and DHEA binding to 
CYP21A2 and 3βHSD respectively by one of the phytoestrogens, diadzein, at a Ki value of 
2.9 μM. In the study, Ohno et al. (2002) suggested that the C6 and C3’ hydroxyl groups on 
ring A and ring B of the flavonoids respectively were responsible for the inhibition of the 
steroidogenic  enzymes.  The  study  showed  that  4’-hydroxyflavone, 6 -hydroxyflavone and 
apigenin with hydroxyl groups at C4’, C5 and C7 significantly inhibited cortisol biosynthesis 
(Ohno et al. 2002). In the present study, the moieties at the above mentioned positions on the 
flavones and isoflavones in Rooibos could be responsible for the decrease in cortisol 
biosynthesis and total steroids under basal and forskolin stimulated conditions. However, 
changes in the 16OH-PROG levels will indicate an effect on CYP17A1 within 
steroidogenesis in the H295R cells, as this metabolite is a dead-end product that is not 
metabolised further. Under basal conditions, 16OH-PROG levels decreased in the presence of 
both Rooibos extracts, with a significant reduction detected in the presence of fermented 
Rooibos extract (3.9-fold). A similar inhibitory effect was obtained under stimulated 
conditions.  
Data obtained from COS-1 cells expressing CYP21A2 indicated that the activity of this P450 
enzyme is most sensitive to Rooibos extracts, as has also been shown in previous studies 
(Perold 2009; Schloms & Swart 2014). Under basal conditions in the H295R cells, regarding 
the conversion of PROG to DOC as well as 17OH-PROG to deoxycortisol, it was only the 
latter that was significantly decreased (P < 0.01) by fermented Rooibos extracts. However, 
under stimulated conditions, both DOC and deoxycortisol levels were decreased significantly 
(P < 0.01), with unfermented Rooibos extracts decreasing only deoxycortisol levels 
significantly (P < 0.01). The decrease in the levels of DOC and deoxycortisol resulted in 
lower levels of precursor metabolites being available for CYP11B2 and CYP11B1 in the 
mineralocorticoid and glucocorticoid pathways. Nevertheless, cortisol levels were decreased 
significantly in the presence of fermented Rooibos only under basal and forskolin stimulated 
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conditions. In addition, 11βOH-A4 levels were reduced under basal and forskolin stimulated 
conditions in the presence of Rooibos extract, suggesting the inhibition of CYP11B1, which 
reflects the data obtained in the COS-1 cells expressing CYP11B1. 
The data obtained in this study shows that the fermented Rooibos extracts exhibited a greater 
inhibitory effect on steroidogenesis in the H295R cells, as well as on the steroidogenic 
enzymes expressed in COS-1 cells. Although the data obtained from the COS-1 cells is 
reflected in the inhibition of steroid metabolites in the adrenal cell model used in this study, 
further experiments and analyses will have to be conducted to confirm the differences 
observed in the data obtained using fermented and unfermented extracts.  
5.5. Conclusion 
From these observations it can be concluded that Rooibos, both unfermented and fermented, 
influences the catalytic activity of steroidogenic enzymes and thus modulates steroidogenesis. 
These findings provide scientific evidence that rooibos herbal infusions may influence the 
endocrine system via adrenal steroidogenesis and may have health benefits in the 
management of endocrine related diseases. 
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CHAPTER 6 
Conclusion 
The argument made for medicinal and health benefits of Rooibos infusions are based partly 
on scientific evidence and partly on anecdotal evidence. There is much epidemiological 
evidence that diets rich in the bioactive compounds found in plants can reduce the incidence 
of non-communicable endocrine related diseases, such as cardiovascular diseases, diabetes, 
cancer and stroke. To date, there is limited information on the effects of Rooibos 
consumption on cytochrome P450 enzymes. As a result, it is imperative to investigate the 
possible effects of Rooibos, and of its phenolic secondary metabolites, on the endocrine 
system, specifically with regard to the P450 enzymes. In this study, the focus was thus on the 
influence of Rooibos and major Rooibos flavonoid compounds on some of the key P450 
enzymes involved in adrenal steroid hormone biosynthesis. Adrenal hormones play a crucial 
role in some of the endocrine related diseases, such as stress, anxiety, diabetes and 
hypertension.  
Since adrenal steroid biosynthesis may be influenced by Rooibos interfering with or 
influencing the binding of natural substrates to P450 enzymes, this aspect was investigated in 
ovine microsomal and mitochondrial preparations. It was shown that unfermented and 
fermented Rooibos extracts, at similar concentrations, interfered with DOC binding to the 
mitochondrial P450 enzymes (CYP11B1 and CYP11B2) to a greater degree than PROG 
binding to the microsomal P450 enzymes (CYP17A1 and CYP21A2). In addition, substrate 
binding to CYP17A1 and CYP21A2 was inhibited to a greater extent with unfermented 
Rooibos extract than with fermented Rooibos extract. The influence of selected flavonoids, 
namely aspalathin, quercetin and rutin, was subsequently assayed. Microsomal P450 enzymes 
were inhibited by rutin to a greater extent than quercetin, although quercetin showed greater 
substrate binding inhibition of mitochondrial enzymes. These investigations also showed that 
aspalathin did not affect substrate binding in a dose dependent manner. In this investigation, 
rutin exhibited greater inhibitory capabilities than quercetin at half the concentrations used 
for quercetin. The inhibition by rutin and quercetin may be attributed to the structural 
similarities they have with the natural substrates (PREG and PROG), hence their name 
phytoestrogen. The differences detected in the interference of substrate binding to the P450 
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enzymes by the Rooibos extracts may be due to the degradation of the polyphenols as a result 
of their instability during the fermentation process. In addition to the structural similarities 
with natural substrates, it is also possible that these flavonoids could have interfered with the 
electron transport system discussed in Chapter 3, as it is widely reported that polyphenolic 
compound can act as electron scavengers.  
Taken together, the substrate binding study showed that rooibos extracts, as well as the 
selected flavonoids, interfered with substrate binding to adrenal P450 enzymes. This data, 
however, does not necessarily imply that the catalytic activity of P450 enzymes is influenced; 
hence substrate conversion assays in COS-1 cells and H295R cells were carried out to 
complete the second aim. 
The influence of unfermented and fermented Rooibos extracts and selected flavonoids on the 
catalytic activity of P450 enzymes expressed in the COS-1 cells showed that fermented 
extracts inhibited the catalytic activity of both microsomal and mitochondrial P450 enzymes 
to a greater degree than unfermented extracts. It is interesting to note that, while none of the 
selected flavonoids influenced CYP11B1’s catalytic activity,  the microsomal enzymes were 
inhibited by these compounds. The inhibition of the catalytic activity of CYP21A2 by 
quercetin was greater than by rutin and aspalathin, and while rutin had a greater inhibitory 
effect on CYP17A2 than quercetin and aspalathin, the latter inhibited the catalytic activity of 
CYP17A1 only. Further experiments need to be conducted to establish the mechanisms by 
which Rooibos flavonoid compounds inhibit P450 enzymes. Although the Rooibos 
compounds assayed were shown to interfere with the binding of natural substrates to specific 
enzymes, it has not been established whether these compounds bind to the active site, or 
whether they bind to another domain on the protein molecule, possibly leading to a 
conformational change hampering substrate binding. An investigation of competitive, 
uncompetitive and/or non-competitive inhibition by flavonoid polyphenols may shed light on 
the differences observed in the binding and conversion assays that were conducted in this 
study.  
In the view of the fact that Rooibos extracts had an effect on substrate binding to P450 
enzymes and substrate conversion by P450 enzymes, the effect of unfermented and fermented 
Rooibos extracts on adrenal steroidogenesis was investigated in an adrenal cell model, the 
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H295R cell line. Although the data shows that, in the presence of Rooibos extracts, total 
steroid hormone production decreased in the H295R cells, it is clear that, under basal 
conditions, total steroid levels were decreased to a lesser degree, with a more pronounced 
decrease in total steroid production being detected in the presence of both unfermented and 
fermented extracts under forskolin stimulated conditions. The analyses also showed that a 
decrease in the levels of the products of reactions catalysed by CYP17A1 (specifically 16-
OHPROG), CYP21A2 (DOC, deoxycortisol), CYP11B1 (cortisol) and CYP11B2 (CORT) 
will result in a decrease in the end products of adrenal steroidogenesis. The data obtained also 
reflect the inhibition detected in the COS-1 cells assays, in which substrate conversions 
catalysed by CYP17A1, CYP21A2, CYP11B1 and CYP11B2 inhibition were greater in the 
presence of fermented extracts than in the presence of unfermented extracts. It can be 
concluded that unfermented and fermented Rooibos affect adrenal steroidogenesis in H295R 
cells by decreasing the amount of total steroids produced. It is clear that the decrease 
observed in precursor levels consequently leads to the decrease in aldosterone and cortisol 
levels, most prominent under forskolin stimulated conditions, suggesting that Rooibos may 
aid in the treatment of hypertension and stress related diseases. 
It generally can be concluded that the inhibition detected in the substrate binding assays and 
in the substrate conversion assays, as well as the effect of Rooibos extracts on steroidogenesis 
in H295R cells, cannot be attributed specifically to the flavonoids analysed, as 46 flavonoid 
compounds have been identified in Rooibos to date, some of which are present at higher 
levels than those analysed in this study. It is also possible that, of all the flavonoids present in 
Rooibos, some may inhibit steroidogenic enzymes, while others may not, and while some 
may have no effect at all, polyphenols may also stimulate these enzymes. 
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